Introduction {#s1}
============

The brain is an energetically demanding organ that contains kilometers of capillaries to meet this need. Capillaries are the smallest vessels in the brain and serve as the primary site of nutrient and gas exchange ([@bib4]). These capillary networks are critical for maintaining proper brain function since decrements in cognition that occur with aging and certain neurodegenerative diseases (like Alzheimer's disease) are associated with the loss of brain capillaries ([@bib7]; [@bib25]; [@bib44]). From the earliest in vivo imaging studies of cerebral blood flow over two decades ago, the susceptibility of capillaries to obstruction, even in healthy animals has been noted ([@bib31]; [@bib46]; [@bib61]). A recent study used Optical Coherence Tomography to estimate that over 9 min, up to 7.5% of capillaries experienced a stall ([@bib11]). This is not surprising since capillaries are inherently narrow (\~3--5 µm diameter) high resistance tubes that must pass relatively large and adherent components in the blood (red blood cells, leukocytes, cholesterol, fibrin etc.). Cortical capillaries also experience the largest drop in pressure across the cerebral vasculature ([@bib17]). However, since the initial in vivo observations, no study has comprehensively followed the long-term outcome of capillary obstructions and what mechanisms dictate their fate. This leaves open many questions that are critical to our understanding of how mature microvascular networks change. For example, if obstructions are almost always cleared or compensated for with collateral sprouting, then the impact of these obstructions could be minimal. If, however, obstructions lead to the pruning of vessel segments, then it is conceivable that the accumulation of these events over a time could drive the progressive rarefaction of cerebrovascular networks commonly found with aging ([@bib35]; [@bib30]; [@bib22]; [@bib9]; [@bib8]; [@bib29]; [@bib1]) and certain neurodegenerative diseases ([@bib7]; [@bib25]; [@bib57]).

In order to understand what ultimately becomes of obstructed cortical capillaries and the mechanisms that regulate their fate, we employed in vivo time-lapse imaging to identify and follow spontaneous, naturally occurring obstructions in mouse cortex. Due to the unpredictable and sparse nature of these obstructions, we also developed and validated an experimental model of inducing capillary obstructions with fluorescent microspheres. Although we find that the majority of capillary obstructions are cleared, almost one-third of obstructed capillaries are pruned without compensatory angiogenesis. Based on this information and the relative incidence of naturally occurring obstructions, we were able to model capillary loss with aging. Furthermore, we show that VEGF-R2 (encoded by *Kdr*) signaling, a known sensor of shear stress, is critical for mediating clearance of obstructions and preventing capillary pruning. Our findings shed new light on the long-term fates of clogged cortical capillaries and the mechanisms that dictate this process.

Results {#s2}
=======

Superficial and lower order cortical capillaries are prone to obstruction {#s2-1}
-------------------------------------------------------------------------

We first examined how frequent and what parts of the vascular tree were prone to spontaneous obstructions in the mouse somatosensory cortex. We imaged cortical vascular networks (\~300 µm in depth) in both lightly anesthetized (2% isoflurane for induction, 1% for maintenance) and awake *Tek*-GFP mice injected with Rhodamine B to visualize blood flow. We could identify flowing and non-flowing capillaries by the presence or absence of streaking red blood cells (RBCs) ([Figure 1A](#fig1){ref-type="fig"}). Spontaneous naturally occurring obstructions typically presented with a gap in capillary lumen fluorescence (mean lumen diameter of 3.85 ± 1.25 µm) created by stalled cells or debris ([@bib46]) ([Figure 1A](#fig1){ref-type="fig"}, insert, red arrow). Our analysis was restricted to capillary segments lacking flow for longer than 20 min to exclude transient obstructions that affect \~1--7% of capillaries as previously reported ([@bib46]; [@bib11]). Unbiased sampling of cortical vasculature in 16 mice for 2 hr revealed that longer lasting obstructions (\>20 min) were relatively rare, affecting 2 in 20,334 capillaries (\~0.118% capillaries obstructed per day, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"})([@bib42]). While these spontaneous obstructions were rare, 10 of the 16 mice had non-flowing capillaries segments present at the start of imaging, indicating spontaneous obstructions were not unique to a few mice (persisted \>20 min, 20 obstructed capillaries in 10 animals, range of 1--4 per mouse). To confirm this, we injected mice with 1 µm microspheres coated in lipophilic dye DiI solution. Microspheres of this size freely circulate in the blood but become stalled in spontaneously obstructed capillaries, allowing the DiI to leech into the endothelium, creating an indelible stamp of the spontaneous obstruction. Quantifying postmortem DiI-labeled capillaries 3 hr after injection, we found 3.69 ± 0.97 obstructed capillaries per mm^3^ of cortex. Based on estimates of \~20,000 capillaries per mm^3^ ([@bib6]; [@bib58]) this gives a rate of 0.14% spontaneous obstructions per day, nearly identical to our in vivo estimate. Furthermore, the rate of obstructions did not differ between awake and isoflurane anesthetized mice \[% volume obstructed t~(14)~=1.09, p=0.29, % length obstructed t~(14)~=1.79, p=0.10, n~(isoflurane)~=11, n~(awake)~=5 mice\] thereby ruling out spontaneous obstructions as purely artifacts of anesthetics.

![Cortical capillaries are prone to spontaneous obstruction.\
(**A**) Side projection from in vivo two-photon imaging stack (0.027 mm^3^) showing pial surface at the top with labeled plasma (magenta). Insert shows a flowing (Note streaking pattern in line scans caused by RBC movement) and obstructed capillary (no streaks). Red arrow indicates occluding debris/cells. Scale bars are 50 µm and 15 µm for inset. (**B**) Distribution of microsphere obstructed capillaries as it relates to depth from the pial surface determined by confocal imaging from post-mortem brain sections. Red bars indicate the relative amount of microsphere obstructions for each depth expressed as a fraction of total obstructions. Black line indicates fraction of total capillaries by depth (error bars are 95% CI) as well as raw numbers of capillaries/ mm^3^ by depth are provided in parentheses. Note 0.04 obstructions occurred below 1000 μm from cortical surface but are not shown. (**C**) Distribution showing spontaneous and microsphere obstructed capillaries expressed as a function of arteriole branch order and relative to the distribution of all capillaries \[n~(all)~=3 mice, 285 capillaries; n~(spont.)~=5 mice, 21 obstructions; n~(micro.)~=5 mice, 59 obstructions). Note that lower order capillaries are more susceptible to obstruction. Inset illustrates branch order which started with the penetrating arteriole (0 order branch). Scale bar 15 µm. (**D**) Mean branch order of spontaneous or microsphere-induced capillary obstructions (\[one way ANOVA F~(2,360)~=32.36, p\<0.0001, all capillaries compared to spontaneous obstructions unpaired t-test t~(302)~=4.180, p\<0.0001, or microsphere obstructions unpaired t-test t~(342)~=6.95, p\<0.0001; spontaneous vs microsphere obstructions t~(76)~=0.46, p=0.65\]. \*\*\*p\<0.001, n.s. = not significant. Error bars are S.E.M.](elife-33670-fig1){#fig1}

Due to the rare and spontaneous nature of capillary obstructions, we experimentally modeled these events by injecting 4 µm diameter fluorescent microspheres (i.v.; [Figure 1 -- figure supplement 2A, B](#fig1s2){ref-type="fig"} see Materials and methods). Although microspheres accumulated in peripheral organs, particularly the liver ([Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}), injections did not induce any significant changes in body weight, cardiovascular function, hematological chemistry or hematocrit ([Figure 1---figure supplement 2D--J](#fig1s2){ref-type="fig"}), nor did it lead to inflammatory microglia responses or cell death in either the cortex or peripheral organs ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). In the brain, injection of microspheres was sufficient to obstruct 3.67% (95% CI 2.5--4.8%) of cortical capillaries (\~30 min after injection). Although obstructions were spread across the cortex (in an anterior to posterior manner) and thus affected all major cerebral vascular territories ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}), they occurred preferentially in more superficial layers ([Figure 1B](#fig1){ref-type="fig"}) and at lower branch order capillaries ([Figure 1C](#fig1){ref-type="fig"}). These observations were noted in both spontaneously occurring and microsphere-induced capillary obstructions ([Figure 1C,D](#fig1){ref-type="fig"}). Therefore, the risk of obstruction is significantly higher in a subset of superficial and lower arteriole branch order cerebral capillaries.

Fates of obstructed cortical capillaries {#s2-2}
----------------------------------------

We next assessed capillary recanalization rates and their fates using in vivo time lapse imaging. Imaging stacks were focused on regions where we could find natural/spontaneous or microsphere-induced obstructions to boost sampling rates. Over the 21-day imaging period, we found different outcomes for obstructed capillaries. First, all capillaries that did not recanalize were pruned away in a step wise fashion ([@bib14]). Pruning progressed with a pinched endothelial segment at one end followed by the retraction of that segment ([Figure 2A](#fig2){ref-type="fig"}), leaving the remaining segment connected to the adjacent, flowing capillary. Retraction of vessel segments was associated with an increase in endothelial cell nuclei \[unpaired t-test t~(29)~=6.625, p\<0.0001\] around pruned branch points ([Figure 2B](#fig2){ref-type="fig"}), suggesting that endothelial cells regress and integrate into adjacent capillaries, reminiscent of endothelial regression found in development ([@bib14]; [@bib10]). During pruning we occasionally found that the adjacent capillary segments appeared closer together or further apart. However, by measuring inter-capillary distance at time 0 and +21 days, on average we found no significant lasting deformation of the newly separated capillaries compared to controls ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). To our surprise, pruning of vessel segments was never associated with sprouting of new capillaries (0 sprouts in 162 capillaries followed over 21 days). Therefore, compensatory sprouting of capillaries does not occur, or rarely to compensate for pruning.

![Fates of obstructed cortical capillaries.\
**A**) Longitudinal imaging of a spontaneously obstructed capillary (time 0) that failed to recanalize and was subsequently pruned over 31 days. The endothelium is shown in green (*Tek*-GFP) and blood plasma in magenta. Asterisk shows location of linescan. (**B**) Top: Confocal images show endothelial cell nuclei at a branching point adjacent to a presumptively obstructed and pruned capillary segment. Bottom: Pruning of capillaries was associated with a local (within 10 µm) increase in endothelial cell nucleus density \[n = 4 mice, unpaired t~(29)~=6.625, \*\*\*\*p\<0.0001\]. Average 4.6 capillaries per mouse, range 3--6. (**C**) Time lapse images of spontaneous or microsphere-induced capillary obstructions, both of which were cleared within 48 hr. **D**) Clearance of spontaneous (black) or microsphere-induced (blue) capillary obstructions over 48 hr as percent of obstructions at time 0. Recanalization rates were not significantly different between the two types of obstruction \[two-way ANOVA, main effect of group: F~(1,40)~=0.06, p=0.99; n~(spont.)~=5 mice, 36 obstructions, n~(micro.)~=4 mice, 35 obstructions\]. (**E**) Example of a capillary that recanalized by extruding the obstruction through the vessel wall, also known as angiophagy. Note the return of blood flow at +10 days and the displacement of the microsphere in side image projections (also see 3D reconstruction, [Figure 2---video 2](#fig2video2){ref-type="video"}). (**F**) Time lapse images reveal that some capillaries regain blood flow only to be eliminated at a later time. **G**) Time course of all capillaries that failed to recanalize and were pruned (square) compared to those that recanalized and were later pruned (circle). **H**) Summary of microsphere obstructed capillary fates 21 days after injection (n = 14 mice, 162 obstructions). Numbers in parentheses indicate how many capillaries out of 162 total capillaries underwent pruning, angiophagy or recanalized by extrusion. Average 11 capillaries per mouse, range 6--26. Scale bars = 10 µm. Error bars are S.E.M.](elife-33670-fig2){#fig2}

For capillaries obstructed with microspheres, almost all recanalized by extruding the obstruction back into the circulation ([Figure 2C](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}, and [Figure 2---video 1](#fig2video1){ref-type="video"}), while only a small fraction (2%) recanalized by extruding the microsphere through the endothelial wall into the parenchyma, commonly referred to as angiophagy ([Figure 2E](#fig2){ref-type="fig"}; [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"} and [Figure 2---video 2](#fig2video2){ref-type="video"}). However, we should note that we were unable to measure rates of angiophagy associated with spontaneous, naturally occurring emboli, which likely would have influenced the route of recanalization (washout vs angiophagy). Within the first 24 hr, 75--80% of capillaries (stalled \>20 min at time 0) recanalized, which did not differ significantly between spontaneous and microsphere-induced obstructions ([Figure 2D](#fig2){ref-type="fig"}; effect of time: F~(4,40)~=55.29, p\<0.001, effect of obstruction type: F~(4,40)~=0.11, p=0.75). The only vascular factor that predicted recanalization was proximity of the obstruction to the nearest flowing capillary ([Figure 2---figure supplement 3A,B](#fig2s3){ref-type="fig"}). By contrast, capillary branch order, blood flow velocity or lumen diameter in upstream and downstream capillaries was not predictive of recanalization ([Figure 2---figure supplement 3C--G](#fig2s3){ref-type="fig"}). Interestingly by 21 days, 30% of all obstructed capillaries (at time 0) had been eliminated. While one would have expected 20--25% based on recanalization rates in the first 48 hr, we discovered that a subset of capillaries regained blood flow only to be pruned at a later time point ([Figure 2F,G](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"} and [Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"}). This phenomenon could not be predicted by changes in blood flow velocity, width, or flux in the recanalized primary capillary, or connected (secondary) capillaries ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}). However, by inducing a second wave of microsphere obstructions (microsphere injections 4 days apart), we noticed that the probability of experiencing an obstruction was greater in capillaries that were previously obstructed and regained flow ([Figure 2---figure supplement 5](#fig2s5){ref-type="fig"}). Therefore, it is possible that delayed pruning of capillaries in ones that initially regained blood flow, could be explained by a second spontaneous obstruction that was missed in the days between imaging ([@bib11]). In summary ([Figure 2H](#fig2){ref-type="fig"}), by following capillaries for 21 days after an obstruction, we determined there was a 69.8% chance the capillary would be intact and flowing either by extruding the emboli back into circulation (110/162 capillaries) or through angiophagy (3/162 capillaries). There was a 30.2% chance of being pruned (49/162 capillaries), with no evidence of compensatory sprouting. Importantly, the likelihood of capillary pruning did not differ significantly between obstructions that occurred spontaneously versus those that were induced with microspheres (unpaired t-test t~(19)~=0.72, p=0.48).

Impact of capillary pruning on local blood flow {#s2-3}
-----------------------------------------------

From a hemodynamic perspective, capillary pruning led to a transient increase in blood flow velocity and flux (flux estimates volume of blood flowing per second through a vessel) in adjacent capillaries, particularly those upstream of the pruned segment ([Figure 3A--E](#fig3){ref-type="fig"}). By contrast, RBC velocity, vessel width and flux in control capillaries such as those from vehicle injected mice (without microspheres), capillaries distant to obstructions or those adjacent to recanalized capillaries were stable across imaging timepoints ([Figure 3B--E](#fig3){ref-type="fig"}). These results show that capillary pruning induces a relatively long-lasting (over several days) perturbation of blood flow in connected capillary networks.

![Capillary pruning leads to altered blood flow in adjacent connected capillaries.\
**A**) Diagram summarizing measurements taken from secondary/adjacent (2°⁰) capillaries. (**B**) Plots show normalized RBC velocity from individual secondary capillaries after the primary segment recanalized (blue) or was pruned (solid or dashed red). **C-- -E**) Graphs show mean normalized secondary RBC velocity (**C**); Main effect of Group F~(4,151)~=10.27, p\<0.0001), diameter (**D**); Main effect of group F~(4,118)~=2.31, p=0.08) and RBC flux (**E**); Main effect of group F~(4,68)~=3.53, p=0.03) in the 5 groups of capillaries studied. Note that 'vehicle injected' refers to capillaries tracked from mice injected with just vehicle solution and no microspheres (green) and 'distant vessels' refers to capillaries that were distant to any microsphere obstructed capillaries (black) (defined as minimum of 2 branching points away from obstruction). n = 14 mice, 6--20 vessels per group. Average 11 capillaries per mouse, range 4--20. Individual time points followed up with unpaired t-test. \*p\<0.05 compared to vehicle injected, \*\*p\<0.01, \*\*\*p\<0.001. Error bars are S.E.M.](elife-33670-fig3){#fig3}

Lower capillary density in aged mice is predicted by obstruction and pruning rates {#s2-4}
----------------------------------------------------------------------------------

Next, we attempted to predict age-related changes in cortical capillary density based on our experimental estimates of spontaneous capillary obstructions (\~0.118% capillaries obstructed per day) and the likelihood of pruning (30% of all obstructed capillaries). We first replicated well-established reports of an age-related reduction in capillary density ([@bib7]; [@bib44]; [@bib30]; [@bib22]; [@bib9]; [@bib8]; [@bib29]; [@bib1]; [@bib28]; [@bib2]) by comparing vascular networks in young adult and aged *Tek*-GFP mice ([Figure 4A,B](#fig4){ref-type="fig"}; 3--4 vs. 15--18 month-old mice, respectively; 6 and 7 mice per group,\>49,000 capillaries). Based on our analysis, we found a 10 ± 8% loss in capillary density over the 13.5 month age difference ([Figure 4C](#fig4){ref-type="fig"}). For theoretical predictions, we created a hypothetical population of 100,000 capillaries, each assigned a branch order based on our experimentally determined distribution ([@bib42]). We then assigned each branch order a risk of obstruction, based again on our experimental distribution ([Figure 1C](#fig1){ref-type="fig"}). For every 2 hr window the number of capillaries lost for each branch order was simply the number of capillaries x risk of obstruction for that branch order x risk of pruning (30%) ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Comparing the fraction of vessel loss predicted by our model over the course of \~13.5 months (\~405 days, with day 0 representing young adult mouse in [Figure 4C](#fig4){ref-type="fig"}), we found close agreement between experimentally observed and predicted capillary loss (predicted = 88% capillaries remaining vs. measured = 90 ± 8%; Unpaired t-test to hypothetical mean 0.88, t~(6)~=0.68, p=0.52). The predicted loss matched some, but not all, published estimates of age related capillary loss in rats ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) Thus, spontaneous capillary obstruction and subsequent pruning without compensatory sprouting, can account for age related loss in capillary density.

![Lower capillary density in aged mice is predicted by obstruction and pruning rates.\
([**A**]{.smallcaps}) Representative confocal images of Evans blue filled blood vessels in somatosensory cortex of young (3--4 month) and aged (15--18 month) mice. Scale bar 200 µm. (**B**) Box and whisker plot of capillary density (+denotes mean) across all cortical layers for 3--4 and 15--18 month old *Tek*-GFP mice (n = 6--7 mice; unpaired t~(11)~=2.47, p=0.03). Error bars are S.E.M. (**C**) Box and whisker plot of normalized cortical capillary density for 3--4 or 15--18 month old *Tek*-GFP mice (n~(3-4month)~=6, n~(16-18month)~=7 mice, unpaired t~(11)~=2.47, p=0.03). Error bars are S.E.M. (**D**) Predicted capillary loss over time (blue line) based on measured rates of spontaneous obstructions and pruning (see Materials and methods, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Red data points and mean (±SEM) represent measured capillary loss in 15--18 month old aged mice normalized to 3--4 month old mice. Predicted capillary loss closely matched experimentally measured loss in aged mice (unpaired t-test, p=0.52).](elife-33670-fig4){#fig4}

VEGF-R2 signaling dictates capillary recanalization {#s2-5}
---------------------------------------------------

Since the maintenance of capillary network density is important for brain health ([@bib25]), our next goal was to uncover a molecular mechanism dictating capillary recanalization. We focused on Vascular Endothelial Growth Factor Receptor 2 (VEGF-R2) signaling given that it is a critical regulator of endothelial cell function and is very sensitive to changes in hemodynamic shear stress ([@bib40]; [@bib59]). To assess relative levels of VEGF-R2 signaling within individual capillaries that were obstructed vs. those that recanalized, we injected 4 µm microspheres coated in a DiI solution and examined brains 3 hr after injection. As mentioned previously, lipophilic DiI leaches into endothelial cells at the site of the obstruction, therefore leaving an indelible stamp of where the obstruction occurred, even in recanalized capillaries ([Figure 5A](#fig5){ref-type="fig"}). Consistent with the hypothesis that VEGF-R2 signaling is sensitive to changes in blood flow ([@bib27]), obstructed capillaries (30 min after microsphere injection) had significantly lower colocalization with pVEGF-R2-labeled capillaries \[sham 13.41 ± 2.4% compared to obstructed 3.85 ± 1.3%, unpaired t-test t~(30)~ = 3.86, p=0.0006, n~(sham)~=3 mice, 16 vessels, n~(obstructed)~=4 mice, 16 vessels\]. Three hours after microsphere injection when capillaries have begun to recanalize, we identified two distinct populations of recanalized capillaries based on pVEGF-R2 expression co-localization with DiI-labeled endothelium ([Figure 5B](#fig5){ref-type="fig"}, insert). Recanalized capillaries exhibited either significantly lower or higher pVEGF-R2 expression, than capillaries that were still obstructed by microspheres or unobstructed control capillaries ([Figure 5B](#fig5){ref-type="fig"}).

![VEGF-R2 signaling dictates capillary recanalization.\
(**A**) Confocal images show phosphorylated VEGF-R2 (Y1175) immunolabeling in an obstructed capillary (top row, see DiI-coated microsphere) and one that recanalized (bottom row, note DiI labeling of GFP-labeled endothelium without presence of microsphere). (**B**) Histogram shows **%** pVEGF-R2 colocalization with endothelium at the site of an obstructed or recanalized capillary 3 hr after microsphere injection. Sham capillaries were measured from mice injected with vehicle solution but without microspheres. Inset shows the distribution of pVEGF-R2 colocalization values for all recanalized capillaries. Based on this distribution, we used a 20% cut off (dotted line) to separate the two distinct populations. Average eight capillaries per mouse, range 5--11. Note that recanalized capillaries exhibit significantly higher or lower pVEGF-R2 colocalization. n = 83 vessels total with 3 sham and seven injected mice, one way ANOVA F~(3,77)~=22.93, p\<0.0001, unpaired t-test to compare groups. \*p\<0.05, \*\*\*\*p\<0.0001. (**C**) Box and whisker plots (+denotes mean) show normalized density of microspheres in the cortex of saline and VEGF injected (i.c.v.) mice 24 hr after microsphere injection. n = 5 mice per group, unpaired t-test. \*p\<0.05. Microsphere density: Vehicle 7.97 ± 1.3 per mm^3^ versus VEGF injected 22.27 ± 2.1 per mm^3^. (**D**) Summary and timeline of VEGF-R2 knockdown or inhibition experiments. **E**) Left: Immunolabeling for pVEGF-R2 in *Tek*-GFP mice shows reduced vascular expression 3 hr after injection of 50 mg/kg SU5416. Right: Quantification of vascular pVEGF-R2 in Tamoxifen-treated *Tek*CreER^T2^ X *Kdr*^+/fl^ mice \[four mice per group; unpaired t-test, t~(6)~=3.32, p=0.01\] or *Tek*-GFP mice injected with SU5416 \[four mice per group; unpaired t-test t~(6)~=3.17, p=0.02\]. (**F**) Capillary fates 21 days after obstruction in vehicle or tamoxifen treated *Tek* CreER^T2^ X *Kdr*^+/fl^ mice based on in vivo time lapse imaging (n = 6 mice per group, vehicle = 75 capillaries, Tamoxifen = 81 capillaries, Average 10 capillaries per mouse, range 5--16). Unpaired t-test to compare % recanalized, t~(10)~=3.88, p=0.003.\*\*p\<0.01. **G**) Left: Representative images of cortical microspheres in coronal brain sections from vehicle or Tamoxifen-injected *Tek* CreER^T2^ X *Kdr*^+/fl^ mice 21 days after microsphere injection. Scale bar 500 µm. Right: Normalized density of microspheres in the cortex of vehicle and Tamoxifen-injected mice at 4 and 21 days after microsphere injection (n = 4--9 mice; unpaired t-test at 4 days t~(6)~=4.43, p=0.004; and 21 days t~(12)~=2.74, p=0.017.+is mean. \*p\<0.05, \*\*p\<0.01). Microsphere densities (/mm^3^) at +4 days: Vehicle 16.2 ± 1.5, Tamoxifen injected 10.3 ± 5, +21 days: Vehicle 6.38 ± 3, Tamoxifen injected 1.5 ± 0.4. (**H**) In vivo determination of capillary fates after 21 days in vehicle or SU5416 injected *Tek*-GFP mice \[n = 4 mice per group at 4 days, n = 5 for vehicle and n = 9 for tamoxifen injected at 21 days, vehicle = 84 capillaries; SU5416 = 90 capillaries; Average 20 capillaries per mouse, range 16--30, unpaired t~(7)~=2.73, p=0.03\]. **I**) Left: Images show cortical microspheres in brain sections from vehicle and SU5416 treated *Tek*-GFP mice 21 days after microsphere injection. Scale bar 500 µm. Right: Normalized density of microspheres in the cortex of vehicle or SU5416 injected mice at 4 and 21 days \[n = 4 mice per group; unpaired t-test at 4 days t~(6)~=6.97, p=0.004, and 21 days t~(6)~=2.92, p=0.02\]. Microsphere densities (/mm^3^) at +4 days: Vehicle 69.2 ± 1.4, SU5416 injected 31.94 ± 4.2, +21 days: Vehicle 21.59 ± 5.3, SU5416 injected 12.21 ± 1.33. \*p\<0.05, \*\*p\<0.01, and \*\*\*p\<0.001 compared to vehicle injected. Error bars are S.E.M.](elife-33670-fig5){#fig5}

Although immunohistochemical analysis clearly indicated that VEGF-R2 signaling was altered in recanalized capillaries, its precise role remained ambiguous. Therefore, we utilized gain of function and knockdown experiments to better define the role of VEGF-R2 signaling in capillary recanalization. First, we stimulated VEGF-R2 signaling using our previously validated protocol ([@bib55]) of injecting 25 ng VEGF-A (i.c.v.) just prior to injection of microspheres. VEGF treatment significantly increased obstruction density 24 hr after microsphere injection compared to vehicle-injected mice ([Figure 5C](#fig5){ref-type="fig"}, unpaired t-test, t~(8)~=3.282, p=0.01, only cortex contralateral to injection site was analyzed). Based on the fact that reduced levels of vascular pVEGF-R2 correlated with recanalization in some but not all capillaries, and that increasing VEGF-R2 signaling lowered recanalization rates, we then asked whether reducing VEGF-R2 signaling could improve recanalization rates. For this we employed two approaches ([Figure 5D](#fig5){ref-type="fig"}), an endothelial-specific inducible knockdown of VEGF-R2 signalling (*Tek* Cre-ER^T2^ crossed with floxed Kdr (VEGF-R2) line) or pharmacological inhibition of VEGF-R2 with the blood brain barrier permeable, small molecule inhibitor SU5416 ([@bib12]; [@bib36]; ). Both of these approaches significantly reduced VEGF-R2 signaling as indicated by lower immunohistochemical staining for pVEGF-R2 \[[Figure 5E](#fig5){ref-type="fig"}; tamoxifen vs vehicle: unpaired t-test, t~(6)~=3.32, p=0.01; SU5416 vs vehicle: unpaired t-test t~(6)~=3.17, p=0.02\] or western blot detection of VEGF-R2 protein levels in the cortex ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}).

The impact of reduced VEGF-R2 signaling on capillary recanalization was assessed with in vivo time lapse imaging ([Figure 5F,H](#fig5){ref-type="fig"}) or post-mortem estimates of microsphere density at 4 and 21 days after microsphere injection ([Figure 5G,I](#fig5){ref-type="fig"}). For both types of analysis, rates of capillary recanalization were significantly enhanced when VEGF-R2 signaling was reduced with VEGF-R2 knockdown ([Figure 5F,G](#fig5){ref-type="fig"}) or pharmacological inhibition ([Figure 5H, I](#fig5){ref-type="fig"}). Not surprisingly, improved recanalization was associated with a significant reduction in the number of pruned capillaries at 21 days ([Figure 5F,H](#fig5){ref-type="fig"}). The effects of VEGF-R2 knockdown or inhibition on recanalization rates were not explained by any global cardiovascular changes, as we found no differences in heart rate, breath rate, blood pressure or tissue oxygenation between treated and control groups ([Figure 5---figure supplements 1](#fig5s1){ref-type="fig"}--[2](#fig5s2){ref-type="fig"}). Further, these effects could not be explained by significant differences in the initial density of microspheres injected \[microsphere density 30-min post-injection: vehicle vs. SU5416 = 652 ± 224 versus 562 ± 200 microspheres/mm^3^, t~(6)~ =0.25, p=0.8; vehicle vs Tamoxifen: 509 ± 234 versus 328 ± 70 microspheres/mm^3^, t~(10)~= 2.0, p=0.07\]. Lastly, VEGF-R2 knockdown or inhibition did not significantly alter RBC velocity in either control, recanalized or adjacent vessels ([Figure 5---figure supplements 1](#fig5s1){ref-type="fig"}--[2](#fig5s2){ref-type="fig"}). In conclusion, these experiments indicate that VEGF-R2 signaling plays a critical role in dictating capillary recanalization.

Discussion {#s3}
==========

Here, we used in vivo two-photon imaging to characterize the inherent risk of cortical capillary obstruction in adult mice. We found that on average \~1 in 10,000 capillaries will become obstructed for longer than 20 min within a 2 hr window. However, the risk of obstruction was not equally distributed as superficial capillaries of lower arteriole branch orders (distribution peaks at the 3rd arteriole branch order) were at highest risk ([Figure 1C](#fig1){ref-type="fig"}). While this distribution of obstructed capillaries (as a function of arteriole branch order) bears similarity to a recent study ([@bib11]), we did not quantify risk relative to venous branch order which may have a higher risk for obstruction ([@bib11]). The absolute number of obstructed cortical capillaries might seem quite small; however, it is important to keep in mind that the mouse cortex occupies \~180 mm^3^ ([@bib5]) with an estimated 3.6 million capillaries ([Figure 4](#fig4){ref-type="fig"}) (; [@bib51]19, 33). Therefore, at any given time, one could expect a few hundred obstructed capillaries in the mouse cortex. We would argue that over time, this small fraction of obstructed capillaries could significantly impact cerebrovascular density and blood flow. For example, our data show that \~30% of obstructed capillaries were eventually pruned with no compensatory sprouting. Over a year, we would predict a 12% reduction in capillary density which closely approximates our experimentally determined estimate of vessel loss, as well as others (; [@bib22]; ; [@bib8]; 11-14, 34). In addition to these anatomical changes, we also show that capillary pruning locally perturbs blood flow and flux in adjacent capillary segments for several days. This supports previous experimental work ([@bib49]) showing that capillary occlusion alters blood flow in branches up and downstream of the occlusion. Other work has shown through modelling that microvessel loss can lead to abnormalities in local perfusion (). Thus, despite the highly interconnected nature of the capillary bed, even a small number of pruning events can significantly alter local blood flow and capillary density.

Microsphere model of obstruction {#s3-1}
--------------------------------

Previous studies have injected relatively large (10--100 µm) microspheres in adult rodents to model multiple small ischemic strokes (; ; [@bib41]; [@bib45]; ) or to identify novel mechanism of vessel recanalization ([@bib33]; [@bib18]). Here we used small 4 µm diameter microspheres to selectively obstruct capillaries in an attempt to model spontaneous, naturally occurring capillary obstructions in the brain. Taking this approach provided several experimental advantages. Due to their small size, microspheres can be injected through the tail vein instead of through more invasive routes, such as the internal carotid artery which is believed to be required for emboli larger than 10 µm to reach the brain. The non-invasive nature of these injections facilitates repeated injections and minimizes exposure to anesthetics needed for injections into the carotid. The small size of the microspheres allows them to be dispersed throughout the brain. While we did not find any differences in the anterior to posterior distribution of microspheres in dorsal cortex (from −2 mm to +1.5 mm relative to bregma), this does not take into account regional differences that may exist in more anterior, posterior and lateral cortical regions. Since regional vulnerability to capillary obstruction has relevance to pathophysiology, future work will be needed to characterize the risk of obstruction and pruning across the cortical mantle or subcortical regions. We have also exhaustively validated this model of obstruction. First, we have established that our dosage of microsphere injection did not cause detectable changes in global cardiovascular parameters and blood chemistry ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Thus, while microspheres do obstruct vessels in other organs, they do not induce cell death, or organ dysfunction. A future question will be to study capillary obstructions in other organ systems to see how the risk of obstructions, and ultimate fates vary in different systems. Angiophagy for example was first described in brain vasculature but turned out to be a universal property of most vessels ([@bib18]). Second, how the brain deals with microsphere obstructions yielded similarities with those that occur spontaneously. For example, rates of capillary recanalization and eventual pruning of obstructed capillaries were similar between the two types of obstructions (microsphere vs natural emboli). A third advantage is that microspheres can be coated with lipophilic dye DiI, thereby allowing us to tag obstructed vessels, even after they had recanalized. This method will be useful for furthering our understanding of the signaling events that occur and differentiate recanalized capillaries versus those that remain obstructed.

However, there are important caveats that should be noted with the microsphere model. Foremost is the fact that the composition (polystyrene microsphere vs. fibrin, blood cells) and size of the obstruction likely affects the route of recanalization. While we found low rates of angiophagy with microsphere obstructions, this likely would not be the case with larger and more natural emboli (such as cholesterol or fibrin-based clots). For example, Lam et al. showed different rates of washout versus angiophagy between natural emboli compared to microspheres ([@bib33]). A second caveat that could not be avoided was that we were unable to inject microspheres without the use of anesthesia. Anesthetics such as isoflurane have pleiotropic effects that influence synaptic transmission, blood flow and ischemic cell death ([@bib47]; [@bib62]; [@bib52]). Therefore, we cannot completely rule out a possible effect of even brief isoflurane exposure (in awake imaging or histology experiments) on microsphere obstruction density, as others have reported anesthetic effects on capillary stalling ([@bib11]; [@bib47]).

Vascular remodeling in the mature brain {#s3-2}
---------------------------------------

Our finding that a failure to remove obstructions inevitably leads to capillary pruning suggests that the accumulation of obstructions over time is at least partially responsible for the loss of microvascular density in aging reported by us and others ([Figure 4](#fig4){ref-type="fig"}) ([@bib30]; [@bib22]; ; [@bib8]; ; [@bib1]; [@bib2]; [@bib20]) \[see ([@bib44]) for review, but also (; [@bib24]) for studies failing to find age related losses in capillaries)\]. The fact that vessel pruning was not compensated for with sprouting (angiogenesis) is significant, but should not be viewed as completely surprising since other in vivo longitudinal imaging studies of cortical microcirculation have found scant evidence for angiogenesis (at least below the cortical surface) in the mature brain ([@bib43]; ; [@bib56]; 31, 34, 49, 50). Furthermore, since our obstructions targeted a small fraction of capillaries and therefore did not lead to hypoxia or cell death, the hypoxia-related signals needed to trigger angiogenesis would not be present.

Our estimate of capillary loss in the aged mouse cortex, while closely matching our predicted loss and many other studies, would seem conservative to some prior reports ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Discrepancies in empirical estimates of capillary loss with age may reflect different methodologies for visualizing capillaries. Our measurements were based on intravenous injection of fluorescent dyes therefore labeling flowing capillaries in the brain with very high signal to noise. However, this could slightly overestimate the density of patent capillaries since injected plasma dyes also filled stalled capillaries given that we never found a *Tek*-GFP-labeled capillary without fluorescent dye present in it. Importantly, our Evans-blue-based estimates of vessel density in young adult mice closely matches other published studies (; [@bib51]20, 33), particularly those by the Kleinfeld lab (; [@bib58]). In contrast, many previous studies in rats have used histochemical staining for alkaline phosphatase ([@bib29]; [@bib1]; ; [@bib2]15, 16, 23, 24) or electron microscopy ([@bib9]) to estimate vessel density. The caveat of using alkaline phosphatase staining is that it assumes ubiquitous vascular expression that does not vary with age (independent of vessel loss), while electron microscopy studies are constrained by very low sample sizes. Another obvious factor underlying discrepancies in capillary loss could be the experimental animal studied since most previous studies used rats. While we are confident that our predictions are well suited for mice, it would be interesting to know if it could be applied to other larger and longer-lived species. Future studies, perhaps replicating our approaches for estimating capillary obstruction and clearance rates, as well as capillary density in aging animals would be necessary to extend our predictions.

Mechanisms of recanalization {#s3-3}
----------------------------

Historically, the main mechanism of recanalizing a cerebral microvessel was believed to be through Tissue Plasminogen Activator (TPA), which was provided by microvascular endothelial cells ([@bib64]). However, previous work has shown in larger vessels the window for TPA-mediated recanalization is short (; [@bib18]42, 43), and many types of obstructions are not susceptible to thrombolytics. The recent discovery of angiophagy (; [@bib18]42, 43) in penetrating arterioles and capillaries suggested different strategies exist for clearing obstructions. Our finding of an angiophagy-like process where endothelial cells engulf and extrude emboli through the vessel wall replicates previous findings of the Grutzendler lab (; [@bib18]42, 43). However, we cannot rule out the possibility that leukocytes (which were not labelled in our study) could have engulfed microspheres and transported them across the capillary wall. Due to the low incidence (2%) of angiophagy-like events in our microsphere model, we could not extensively characterize this process. Further, the manner and frequency of angiophagy-like events is likely influenced by the specific size of emboli and its composition. For example, larger occlusions (\>4 µm) would have more severe consequences such as hypoxia and cell death ([@bib24]) which can trigger major structural changes in the vascular endothelium through hypoxia-inducible factors. An intriguing question that has not been resolved is what mechanisms mediate the dislodging and extrusion of obstructions back into the circulation. Although we know that VEGF-R2 signalling plays a critical role in recanalization, we do not know the precise mechanisms through which it acts. For example, VEGF-R2 is coupled to nitric oxide and other signaling pathways ([@bib27]) that could mediate a change in vessel tone or diameter in the obstructed capillary. However, a recent study has questioned the role of NO as a major capillary dilator ([@bib37]), thus other pathways may be involved. We should also note that heamodynamic forces from up or downstream capillaries are not likely a critical factor since measured levels of blood flow or diameter in these capillaries did not precede or predict capillary recanalization ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Another possibility that will require further study is whether pericytes facilitate recanalization or pruning. In particular, smooth muscle actin-positive pericytes, which are found at precapillary arterioles and lower branch order capillaries, have been shown to regulate capillary flow ([@bib21]). Furthermore, ischemic stroke leads to prolonged pericyte constriction which can limit blood flow in capillaries ([@bib21]; [@bib19]53, 54). Therefore, it is possible that pericytes may contribute to capillary recanalization by regulating microvessel tone or vasomotion. Pericytes could also play a significant role in vessel pruning since they are hotspots of matrix metalloprotease activity associated with BBB disruption, ([@bib60]) which is needed for remodeling of the extracellular matrix and basement membrane around capillaries. The only variable that differentiated recanalization successes versus failure was distance to the nearest flowing vessel, which suggest at least a more complex interplay between vessel tone and heamodynamic forces. The precise mechanisms by which vessel tone and blood flow intersect to dislodge and extrude persistent emboli will require further study.

Microvascular obstructions and cognitive impairment {#s3-4}
---------------------------------------------------

Although not the focus of the present study, it is very likely that the incidence of capillary obstructions and the rate of recanalization and pruning could be strongly influenced by disease states. Indeed, a recent study ([@bib46]) showed that rates of capillary obstruction were significantly elevated in blood disorders with excessive production of platelets and RBCs. It is now accepted that there is a strong vascular component to many types of dementia (; [@bib57]3, 17). While the umbrella of Vascular Cognitive Impairment (VCI) encompasses many different vascular pathologies, microvessel loss is an important one (; [@bib44]; [@bib57]; [@bib34]). Our study offers at least one mechanism for the loss of microvessels in the healthy aging brain, therefore it is tempting to speculate that similar mechanisms could be at work for known risk factors of dementia such as diabetes or hyperlipidemia. To our knowledge, no study has tracked capillary obstructions and their long-term fates in animal models of VCI. In this sense, we anticipate our study will provide a useful framework for understanding microcirculatory changes that accompany, and possibly underlie cognitive impairment. Furthermore, since we have shown that VEGF-R2 plays a critical role in dictating capillary recanalization, future studies could apply this knowledge to ameliorate disturbances in brain circulation and function/cognition in neurological conditions with a known vascular connection.

Materials and methods {#s4}
=====================

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\                      Designation                            Source or reference                                               Identifiers                                                                                                                                     Additional information
  or resource                                                                                                                                                                                                                                                                                           
  -------------------------------------------- -------------------------------------- ----------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene                                                                                NA                                                                                                                                                                                                                

  Strain, strain background (*Mus musculus*)   Tek-GFP                                The Jackson Laboratory                                            Tie2-GFP_JacksonLab:003658\                                                                                                                     2--4 month-old males, and 16--18 month old males and females used
                                                                                                                                                        (IMSR Cat\# JAX:003658, RRID:[IMSR_JAX:003658](https://scicrunch.org/resolver/IMSR_JAX:003658))                                                 

  Strain, strain background (*M. musculus*)    Kdr^fl/fl^                             Drs. Jane Rossant and Andras Nagy ([@bib13])                                                                                                                                                                      2--4 month-old males

  Strain, strain background (*M. musculus*)    Tek-CreER^T2^                          EMMA                                                              Tie2-CreER^T2^\_EMMA:00715                                                                                                                      2--4 month-old males

  Genetic reagent (*M. musculus*)              Tek-CreER^T2^ X *Kdr*^+/fl^            in house breeding ([@bib36])                                                                                                                                                                                      Tek-CreER^T2^ mice ([@bib34]) (EMMA 00715) bred with *Kdr*^fl/fl^ line ([@bib13])

  Cell line                                                                                                                                                                                                                                                                                             

  Transfected construct                                                                                                                                                                                                                                                                                 

  Biological sample                                                                                                                                                                                                                                                                                     

  Antibody                                     pVEGF-R2                               Cell Signaling                                                    19A10 Rabbit mAb \#2478                                                                                                                         (1:300) For IHC

  Antibody                                     Cy5 conjugated secondary               Invitrogen                                                        A10523                                                                                                                                          (1:400) For IHC

  Antibody                                     VEGF-R2                                Cell Signaling                                                    CS2479s                                                                                                                                         (1:1000) For WB

  Antibody                                     β-actin                                Sigma                                                             A-5441                                                                                                                                          (1:2000) For WB

  Antibody                                     Goat anti-rabbit IgG-HRP               Cell Signaling                                                    7074S                                                                                                                                           (1:1000) For WB

  Antibody                                     goat anti-mouse IgG-HRP                KPL                                                               ([@bib44]; [@bib31]; [@bib46]; [@bib61];[@bib11]; [@bib17]; [@bib35];[@bib30];[@bib22];[@bib9]; [@bib8];[@bib29]; [@bib1]; [@bib57];[@bib42])   (1:1000) For WB

  Recombinant DNA reagent                                                                                                                                                                                                                                                                               

  Sequence-based reagent                       floxed *Kdr* Wildtype                  Integrated DNA Technologies (IDT)                                 5'-TGG-AGA-GCA-AGG-CGC-TGC-TAG-C-3'                                                                                                             30 μM

  Sequence-based reagent                       floxed *Kdr* Flx                       Integrated DNA Technologies (IDT)                                 5'-CCC-CCT-GAA-CCT-GAA-ACA-TA-3'                                                                                                                30 μM

  Sequence-based reagent                       floxed *Kdr* Common                    Integrated DNA Technologies (IDT)                                 5'-CTT-TCC-ACT-CCT-GCC-TAC-CTA-G-3'                                                                                                             30 μM

  Sequence-based reagent                       Cre Fwd                                Integrated DNA Technologies (IDT)                                 5'-CGA-GTG-ATG-AGG-TTC-GCA-AG-3'                                                                                                                30 μM

  Sequence-based reagent                       Cre Rev                                Integrated DNA Technologies (IDT)                                 5'-TGA-GTG-AAC-GAA-CCT-GGT-CG-3'                                                                                                                30 μM

  Peptide, recombinant protein                 VEGF165 protein                        Sigma                                                             V4512                                                                                                                                           1 µL of 25 ng in artificial cerebrospinal fluid

  Commercial assay or kit                      BCA protein assay                      Pierce                                                            \#23225                                                                                                                                         562 nm absorbance

  Chemical compound, drug                      BioRad Clarity Western ECL Substrate   BioRad                                                            Cat\# 107--5061                                                                                                                                 

  Chemical compound, drug                      microspheres (4 μm diameter)           Life Technologies                                                 F8858                                                                                                                                           2% solids; peak emission 605 nm

  Chemical compound, drug                      Rhodamine B dextran                    Sigma                                                             R9379                                                                                                                                           4%, average molecular weight 70,000, in 0.9% saline

  Chemical compound, drug                      FITC dextran                           Sigma                                                             46945                                                                                                                                           4%, average molecular weight 70,000, in 0.9% saline

  Chemical compound, drug                      Evans blue                             Sigma                                                             E2129                                                                                                                                           2% in 0.9% saline

  Chemical compound, drug                      Tamoxifen                              Sigma                                                             T5648                                                                                                                                           five daily intraperitoneal injections of 125 mg/kg dissolved in corn oil, Sigma, C8267

  Chemical compound, drug                      SU5416                                 Tocris                                                            Cat\# 3037                                                                                                                                      50 mg/kg, 0.5% w/v carboxy methyl cellulose, 0.9% sodium chloride, 0.4% polysorbate, 0.9% benzyl alcohol in dH2O

  Chemical compound, drug                      Hoechst 33342                          Thermoscientific                                                  CA\#62249                                                                                                                                       (1/10,000)

  Chemical compound, drug                      DiI                                    Thermoscientific                                                  CA\#D282                                                                                                                                        30 mg DiI dissolved in 5 mL 100% EtOH

  Software, algorithm                          Fluoview                               Olympus                                                           FV10-ASW 4.2                                                                                                                                    

  Software, algorithm                          FIJI                                   Max Planck Institute of Molecular Cell Biology and Genetics 58)   (Fiji, RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285))                                                                            

  Software, algorithm                          ImageJ                                 Wayne Rasband, NIH USA                                            ImageJ 1.47 v\                                                                                                                                  
                                                                                                                                                        (National Center for Microscopy and Imaging Research: ImageJ Mosaic Plug-ins, RRID:[SCR_001935](https://scicrunch.org/resolver/SCR_001935))     

  Software, algorithm                          MATLAB                                 Mathworks                                                         R2017a\                                                                                                                                         Institutional Licence
                                                                                                                                                        (MATLAB, RRID:[SCR_001622](https://scicrunch.org/resolver/SCR_001622))                                                                          

  Software, algorithm                          VesselNumEst                           This paper                                                        Source code 1                                                                                                                                   Runs as macro in ImageJ, available at [https://github.com/ preeson/eLIFE2018-Software](https://github.com/) (copy archived at <https://github.com/elifesciences-publications/eLIFE-2018-Software-Reeson>)

  Software, algorithm                          Capillary Loss Modeling                This paper                                                        Source Code 2                                                                                                                                   Runs in MATLAB with Database S1 as input, available at [https://github.com/ preeson/eLIFE2018-Software](https://github.com/) (copy archived at <https://github.com/elifesciences-publications/eLIFE-2018-Software-Reeson>)

  Other                                                                                                                                                                                                                                                                                                 
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Animals {#s4-1}
-------

We used 2--4 month, and 16--18 month old *Tek*-GFP mice (The Jackson Laboratory, 003658), or *Tek*-CreER^T2^ mice ([@bib13]) (EMMA 00715) bred with *Kdr*^fl/fl^ line ([@bib23]) to generate *Tek*-CreER^T2^ X *Kdr*^+/fl^ mice. Male mice were used in all experiments except for determining capillary density in 3--4 versus 16--18 month mice ([Figure 4](#fig4){ref-type="fig"}), in which retired breeders (male and female) were compared to gender matched 3--4 month-old *Tek*-GFP mice. No differences in capillary density were found by sex, so data were pooled (3--4 month male versus female Unpaired t~(4)~=0.69, p=0.52; 16--18 month males versus females Unpaired t~(5)~=1.36, p=0.23). Offspring were genotyped using the following primers for floxed *Kdr* (WT: 5'-TGG-AGA-GCA-AGG-CGC-TGC-TAG-C-3' and Flx: 5'-CCC-CCT-GAA-CCT-GAA-ACA-TA-3', and common: 5'-CTT-TCC-ACT-CCT-GCC-TAC-CTA-G-3') and Cre (5'-CGA-GTG-ATG-AGG-TTC-GCA-AG-3' and 5'-TGA-GTG-AAC-GAA-CCT-GGT-CG-3'). Mice were housed under 12 hr light/dark cycle and given *ad libitum* access to water and laboratory diet. All experiments were conducted according to the guidelines set by the Canadian Council of Animal Care, ARRIVE, and approved by the University of Victoria Animal Care Committee, protocol 2016-016.

Cardiovascular measurements {#s4-2}
---------------------------

Blood pressure was measured using a commercially available system (Kent Scientific Mouse CODA). Mice were lightly anesthetized (1% isoflurane) and placed on a heating pad with body temperature maintained at 37°C. Tissue oxygenation (% 0~2~ saturation), heart rate (beats/min), and breathing rate (breaths/min) were measured with the commercially available Starr Mouse Ox system (Starr Life Sciences Corp.). Values for each time point were taken as the average of at least 5 min of continuous recording. Blood chemistry was measured using Abaxis VetScan i-STAT system (with CG8 +cartridges). To obtain blood (\~100 μL) for analysis, mice were anesthetised with isoflurane and rapidly decapitated.

Cranial window surgeries {#s4-3}
------------------------

Mice were anesthetized with isoflurane (2% induction, 1.3% maintenance) in medical grade air and fitted into a custom-made surgical stage with body temperature maintained at 37°C. A 0.03 mL bolus of 2% dexamethasone was given intramuscularly to reduce inflammation associated with the procedure. Following a midline incision and retraction of the scalp, a custom metal ring (outer diameter 11.3 mm, inner 7.0 mm, height 1.5 mm) was affixed to the skull with cyanoacrylate glue. Using a high-speed dental drill, a 4 mm diameter craniotomy was made overlying the somatosensory cortex. Cold HEPES-buffered artificial cerebrospinal fluid (ACSF) was applied to the skull intermittently during the drilling procedure to keep the brain cool and reduce inflammation. The dura was left intact and a 5 mm coverslip (no. one thickness) was placed over the brain and secured to the surrounding skull with cyanoacrylate glue and dental cement. The surrounding skin was then secured to the edges of the metal ring with cyanoacrylate glue. Mice were allowed to recover under a heat lamp before being returned to their home cage. After 4 weeks of recovery, mice that showed significant loss of clarity to the imaging window were excluded from the study.

Microsphere model of capillary obstruction {#s4-4}
------------------------------------------

For inducing capillary obstructions, 20 μL of microspheres (4 μm diameter; 2% solids; peak emission 605 nm; Life Technologies FluoSpheres sulfate, F8858) were mixed with 100 μL of fluorescent dye or saline and injected in the tail vein. For comparing obstruction clearance rates between experimental groups (e.g. mice with treated VEGF-R2 inhibitor or vehicle), a master solution of microspheres was first made, sonicated (3 min) and then aliquoted into separate injection doses which were then assigned to mice randomly. Groups were always run in parallel and balanced between controls and experimental conditions.

In vivo imaging {#s4-5}
---------------

Mice were lightly anesthetized with 1% isoflurane with body temperature maintained at 37°C. Mice were given an intravenous injection of 4% Rhodamine B dextran (Sigma, R9379, average molecular weight 70,000, in 0.9% saline) or FITC dextran (Sigma, 46945, average molecular weight 70,000, in 0.9% saline). The cerebral vasculature was imaged through the cranial window using an Olympus FV1000MPE multiphoton laser scanning microscope equipped with a mode-locked Ti:Sapphire laser (Spectral Physics) tuned to either 850 or 910 nm (for Rhodamine B or FITC dextran, respectively). Laser power delivered by each wavelength ranged from 15 to 50 mW at the back aperture depending on imaging depth. Images were acquired in a stack (2 µm z-step) with either a 40x Olympus IR-LUMPlanFl (NA = 0.8, 0.20 µm/pixel) or 20x Olympus XLUPlanFl water-immersion objective (NA = 0.95, 0.62 µm/pixel), using Olympus Fluoview FV10-ASW software. Emitted light was separated by a dichroic filter (552 nm) and then directed through a bandpass filter (either 495--540 nm or 558--706 nm).

For awake imaging, mice were habituated to imaging in three sessions; one session per day for 3--5 days before the start of the experiment. For each session, mice were very briefly anesthetized, then swaddled in a cotton wrap and restrained in a custom plastic rodent restraint device, modified to allow the head to be fixed in a custom stage for imaging. Mice were allowed to wake up in the restraint device. The duration of restraint was gradually increased from 5 to 30 min over the three habituation sessions. Any mouse that showed abnormal or prolonged signs of distress during habituation or imaging sessions were removed from the study (\~25% of mice). In general, awake-imaging sessions lasted 20--60 min.

Imaging areas were chosen based on the clarity of the window and were located near the center of the cranial window, with penetrating arterioles (identified from surface pial vasculature) in the field of view. For determining the rate of spontaneous capillary obstructions that occur in a 2 hr period, multiple areas were randomly selected and imaged every 10--20 min (\~50--350 µm below pial surface). For longitudinal imaging of spontaneous or microsphere-induced capillary obstructions, 2--4 regions were imaged based on suitable density of occlusions and imaging clarity. Any obstructed capillary with more than one microsphere lodged, or less than two branching points from another obstruction were excluded. In no cases did we observe larger vessels (\>\~4 μm) obstructed by aggregates of multiple microspheres.

Analysis of vascular structure and flow {#s4-6}
---------------------------------------

Blood flow velocity was estimated from a series of 3 line scans conducted on capillaries (≤8 µm in diameter) with a 30 s waiting period between each scan. In each brain region, 2--3 microsphere-obstructed capillaries were selected for line scans (to confirm absence of blood flow) and 1--2 adjacent flowing segments. In all cases, 1--2 capillaries in each region that were both flowing and at least two branching points away from any obstruction were used as within animal control vessels. All analysis for blood flow velocity, vessel lumen diameter, and RBC flux was conducted by two separate independent researchers blinded to experimental condition. To measure RBC velocity, two blinded researchers chose three equally spaced apart RBC streaks from each line scan (each linescan was on average 30.83 ± 1 ms per scan, 2 μm/pixel) and using built in functions of Olympus Fluoview software measured the inverse slope (Δ time/ Δ distance). This was repeated for all three linescans done for a single vessel at each timepoint (30 s apart). Therefore, each single vessel RBC velocity at each timepoint was the average of 18 independent blinded measurements (two experimenters' x 3 linescans x 3 RBC slopes). Any curvilinear slopes were excluded. Capillary diameter was measured at Full Width at Half Maximum (FWHM) from a Gaussian fitted intensity profile (John Lim, IMB. March 2011) drawn perpendicular to the capillary. RBC Flux was calculated assuming laminar flow, as F = π/8\*v\*d^2^ ([@bib49]). Direction of flow was determined from the direction of the slope of RBCs in line scans (upwards or downwards) at all time points. Branching orders were determined for capillaries branching off single penetrating arterioles in each region, and each capillary that could unambiguously be assigned a branch order was included. Obstructed branch orders were determined working backwards from the obstructed capillary to a penetrating arteriole that could be followed to the pial surface and identified as an arteriole.

Estimation of capillary numbers {#s4-7}
-------------------------------

Capillary numbers were estimated using a custom written macro in either ImageJ or FIJI ([@bib50]) (see [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, Source code 1)([@bib42]). Imaging stacks of fluorescently labeled vasculature (rhodamine or FITC dextran) were split into sub-stacks of 10 images (2 µm z step). Sub-stacks were each maximally projected in the z plane, and automatically thresholded using ImageJ function Triangle ([@bib63]), which best identified vascular signal. The total area (of each image) and percent vascular signal (number of pixels after thresholding) was measured after applying a median filter (radius one pixels) to eliminate speckling. The area and vascular signal were then converted from pixels to µm and from 2D to 3D manually. The fractional vascular volume (v/v) and total vascular volume (µm^3^) was then calculated. Thresholded sub-stacks were skeletonized ([@bib3]) to create single pixel linear segments and total vascular length was taken as the total number of skeletonized pixels. From vascular length and area measurements, average vessel width was calculated. Since capillaries constitute the majority of the cortical vasculature ([@bib6]), we estimated the total number of capillaries by dividing the total vascular volume (µm^3^) with the average volume of a single capillary, assuming an average radius of 2 µm and length of 75 µm ([@bib6]) (average capillary volume: 942.48 µm^3^). We should note that flattening sub stacks and then re-projecting across the volume overestimates vascular volume (square vessels rather than cylinders) and underestimates vascular length (loss of length in z direction). Therefore, to validate our estimates we first created a sample set of imaging data (four mice, two imaging areas per animal) and created two independent and blinded manual measurements of vascular length (tracing vasculature by hand in each sub-stack) and capillary number (manual counts). Automated estimates of vascular volume were in agreement with and published data ([@bib58]). Likewise, the automated estimate of capillary numbers agreed with manual counts (paired t test, t~(3)~=0.33, p=0.76).

Recanalization rates and capillary fates {#s4-8}
----------------------------------------

For estimating recanalization rates within the first 48 hr ([Figure 2D](#fig2){ref-type="fig"}), 3--4 regions per mouse were imaged from time 0 (\~30 min after injection of microspheres) and then 6, 12, 24 and 48 hr later. Each imaging session was limited to 40 min total with mice regaining consciousness and returned to their home cage between each session. Recanalization rates were calculated as % of remaining obstructions at each time point for each animal. For long-term assessment of capillary fates, obstructed capillaries (microsphere induced or spontaneous; awake or anesthetized) were imaged at time 0 and then at 2, 4, 10, 15 and 21 days with a small subset of mice imaged up to 31 days. All apparent instances of recanalization were confirmed with vessel line scans. Vessel pruning was directly determined in *Tek*-GFP mice by noting the retraction of GFP-labeled endothelium or indirectly in *Tek* CRE ER^T2^ *Kdr*^+/flx^ mice by the complete the loss of labeled plasma (FITC dextran) in a fully pruned segment.

Aged capillary density measurements {#s4-9}
-----------------------------------

Male and female *Tek*-GFP retired breeders (16--18 months old mice) and gender matched 3--4 month-old *Tek*-GFP mice were anesthetized with isoflurane and intravenously administered 100 µL of 2% Evans blue in 0.9% saline (Sigma, E2129). Evans blue was allowed to circulate for 30 min and then mice were decapitated, and the brain fixed in 4% paraformaldehyde (PFA) in 0.1M phosphate buffered saline (PBS) overnight at 4°C. Brains were sectioned at 100 µm on a Leica vibratome (T1000) and every 3rd section was immediately mounted on charged slide and coverslipped with Fluoromount G (ThermoFisher, 00-4958-02). Aged and young mouse brains were processed and imaged in parallel. All sections were imaged immediately after cutting to minimize the possible leaching out of Evans blue dye that can occur over a 24 hr period. Evans blue was excited using a 635 nm laser and collected using an Olympus confocal microscope with a 10x objective (NA 0.40) and a Cy5 emitter filter (670--720 nm). Confocal image stacks were collected in 2 µm z-steps at a pixel resolution of 1.035 µm/pixel. All imaging parameters, including gain and offset, were kept consistent throughout. Three images of the somatosensory cortex were captured for each animal. For manual capillary counts, two independent blinded researchers z projected (maximal intensity) the middle 24 µm of each stack to minimize capillaries crossing over each other in the projection. Fluorescence levels between different animals were normalized by setting the scale of each image to 40% of the maximum pixel intensity of the brightest vessels. For a segment to be counted as a capillary, it must have been clearly visible and project at least 5 µm from another segment. Vessels with diameters greater than 8 µm were excluded.

Modeling capillary loss over time {#s4-10}
---------------------------------

Capillary loss over time was modelled by custom written software in Matlab R2017a. Distribution of branch orders measured experimentally was applied to a theoretical set of 100,000 capillaries (without structural relationships between them). The risk of obstruction was (Source code 2)([@bib42]), applied to each branch order based on the distribution of obstructed capillaries by branch orders (sum adding to observed rate). For each 2 hr cycle, the number of capillaries in each branch order was multiplied by its assigned risk to give the number of obstructed capillaries in each branch order. The number of obstructed capillaries was then multiplied by the overall risk of pruning (0.30) to calculate the number of pruned capillaries for each branch order, which was then subtracted from the number of vessels in each branch order category. Importantly, the risk of obstruction for each branch order was assumed constant (overall risk, therefore only changed as the distribution of branching orders varied). Individual capillary branch orders (initially assigned) were also fixed and not adjusted by any 'up stream' pruning events (capillaries were modeled without structural relationships between them).

Stimulating or blocking VEGF signaling in vivo {#s4-11}
----------------------------------------------

Cage littermates were randomly selected to either control or VEGF-R2 knockdown/inhibition experimental groups. Cre recombinase activity was induced before microsphere or sham injection by five daily intraperitoneal injections of 125 mg/kg of tamoxifen (Sigma, T5648, dissolved in corn oil, Sigma, C8267), while vehicle injected mice received corn oil alone ([@bib43]; [@bib38]; [@bib54]). In *Tek*-GFP mice, VEGF-R2 activity was inhibited by sub-cutaneous injections of SU5416 every 72 hr ([@bib12]; [@bib36]) (Tocris, 50 mg/kg, 0.5% w/v carboxy methyl cellulose, 0.9% sodium chloride, 0.4% polysorbate, 0.9% benzyl alcohol in dH~2~O) intiated 30 min after microsphere injection.

For stimulating VEGF signaling in the brain, mice were injected with 1 µL of 25 ng of recombinant mouse VEGF165 protein (Sigma V4512) in artificial cerebrospinal fluid (ACSF) or ACSF alone into the left lateral ventricle (2 mm lateral, 0.5 mm posterior of bregma). Twenty minutes after i.c.v injections, 20 µL of microspheres in 100 µL of 0.9% saline was injected into the tail vein. One day after microsphere injection, mice were killed, brains were extracted and fixed overnight in preparation for microsphere density analysis. Only the right hemisphere was used for analysis to avoid confounding effects of the injection site.

Microsphere density analysis {#s4-12}
----------------------------

Coronal brain sections (100 µm thick) from microsphere injected mice were imaged on an Olympus BX51 microscope with a 4x UPlanFLN objective (N.A. 0.13, 456.69 pixels/mm, 1.15 × 0.87 mm) using a Cy3 filter set on an Olympus DP73 digital camera using CellSens software. Images were taken of (every 3^rd^ section) from the most anterior and medial sections of the cortex from +1.70 mm to −2.70 mm from bregma ([@bib15]). An experimenter blinded to condition counted the number of microspheres within cortical regions of interest to estimate microsphere density. To limit variability in total numbers of microspheres injected, mice were run in balanced groups of control and experimental conditions and received injections from the same diluted stock of microspheres. To compare between cohorts each experimental density of a cohort was normalized to the average density of that cohort's control animals. Normalized ratios were then averaged across cohorts (typically each experiment consisted of 2--4 cohorts).

Analysis of endothelial cell regression {#s4-13}
---------------------------------------

To determine endothelial cell (EC) density around pruned vessels, brains of *Tek*-GFP mice (21 days after microsphere or saline injection) were immersion fixed overnight in 4% PFA at 4°C. Brains were then sectioned at 100 µm on a vibratome. Every 3^rd^ section was incubated in Hoechst 33342 (20mM stock, 1:10,000 dilution, Thermoscientific 62249) in 0.1M PBS for 20 min, washed and mounted on charged slides. Hoechst, GFP and fluorescent microspheres were sequentially excited using 405, 488 and 543 nm laser lines, respectively. Sections were imaged using an Olympus confocal microscope with a 20x objective (NA 0.75). Image stacks were collected in 2 µm z-steps at a pixel resolution of 0.31 µm/pixel. An EC was identified and included in the analysis if the Hoechst positive nucleus showed complete colocalization with endothelial GFP signal. All EC within a 100 µm radius of the microsphere were counted.

DiI coating of microspheres {#s4-14}
---------------------------

To coat microspheres (1 or 4 µm diameter), an equal volume of microsphere stock solution was added to DiI solution (30 mg DiI dissolved in 5 mL 100% EtOH) and sonicated for \~1 hr and stirred overnight. The ethanol was then allowed to evaporate overnight at 37°C and the DiI-coated beads were reconstituted in 0.9% saline. Solution was further sonicated for \~1 hr to disperse microspheres. Sham injected controls had an equivalent solution of DiI (no microspheres) evaporated and reconstituted in saline.

Phosphorylated VEGF-R2 immunohistochemistry and analysis {#s4-15}
--------------------------------------------------------

Brains from *Tek*-GFP mice were immersion fixed overnight in 4%PFA and then overnight in 30% sucrose before being cut at 50 µm on a freezing microtome. Free floating sections were incubated in pVEGF-R2 antibody (1:300 dilution, Cell Signaling 19A10 Rabbit mAb \#2478) in 0.1M PBS for 18 hr, washed and then incubated in Cy5 conjugated secondary antibody (1:400; Invitrogen, A10523) for 4 hr. Confocal image stacks were collected with a 20x objective (NA 0.75) in 2 µm z-steps at a pixel resolution of 0.31 µm/pixel.

To assess vascular pVEGF-R2 signal, all three imaging channels (GFP-labeled endothelium, orange-red DiI/microsphere and far red/Cy5 labeled pVEGF-R2) were split and maximally projected (40 µm). A median filter (radius = 2) was run on each image projection and a threshold was applied (Triangle threshold for GFP and Yen/Moments threshold for DiI/microsphere or pVEGF-2). *Tek*-GFP signal pixels were inverted to create a vascular mask which was then subtracted from the pVEGF-R2 signal to isolate only vascular pVEGF-R2 labeling. For estimating pVEGF-R2 in recanalized (DiI with no microsphere) or obstructed (DiI +microsphere) capillaries, an ROI was drawn 15 µm on either side of a microsphere or center of DiI-labeled capillary and signal pixels were measured. The % coverage of pVEGF-R2 along capillaries was determined by dividing pVEGF-R2 signal pixels by GFP-labeled vascular pixels multiplied by 100. Sham injected mice received DiI-treated saline without microspheres.

Western blotting {#s4-16}
----------------

Brains were rapidly removed and the cortex from one hemisphere was dissected and placed immediately in chilled lysis buffer (2 mL/100 mg tissue, CelLytic MT Cell Lysis Reagent for mammalian tissues. Sigma, C322810), and 1 × Halt Proteinase Inhibitor Cocktail and 1 × Halt Phosphatase Inhibitor Cocktail). Samples were sonicated and centrifuged at 14,000 rpm for 15 min at 4°C. Supernatant was then removed and used for gel electrophoresis. The total protein content of the samples was measured with a BCA protein assay kit (Pierce, \#23225, 562 nm absorbance). Twenty micrograms of protein were loaded per well and separated on a 8% SDS polyacrylamide gel followed by transfer to PVDF membranes (Bio-Rad Cat\# 162--0177) at 40V in transfer buffer (25 mM tris, 192 mM glycine, 20% v/v methanol) overnight at 4°C. Membranes were blocked for 5 hr at room temperature with 5% (w/v) bovine serum albumin (BSA, Sigma, A7906) in tris buffered saline containing Tween 20 (TBST) at room temperature and incubated overnight at 4°C with the following primary antibodies: anti-VEGF-R2(1:1000, Cell Signalling, CS2479s) and anti- β-actin (1:2000) as a loading control (Sigma A-5441) diluted in TBST. Goat anti-rabbit IgG-HRP (Cell Signaling, 7074S) and goat anti-mouse IgG-HRP (KPL, 04-18-15) were used as secondary antibodies. Blots were washed in TBST and incubated with the HRP-conjugated antibody (1:1000) in TBST for 1 hr at room temperature. Blots were developed by enhanced chemiluminescence (BioRad Clarity Western ECL Substrate, Cat\# 107--5061) and imaged with a G:BOX Chemi-XR5 (Syngene) gel doc system. Western blot images were processed and quantified by densitometric analysis using Genesys software (version 1.5.3.0, Syngene) and Image Studio Lite (version 5.2, LI-COR Biosciences). Levels of VEGF-R2 were first normalized to the levels of the β-actin loading control and then calculated as fold change of vehicle-injected mice.

Statistics {#s4-17}
----------

Statistical analysis of the data was conducted in GraphPad Prism 5. Relevant two tailed independent or paired t-tests were used to follow up significant one-way or two-way ANOVAs. In some cases, a priori t-tests were used to compare experimental groups. A repeated measure ANOVA was used for blood flow analysis. Outliers were detected using GraphPad Prism Grubbs test, with an alpha value of 0.05. Two capillaries (from different mice) were identified as outliers and were excluded from analysis in [Figure 3](#fig3){ref-type="fig"}. Sample sizes for each experiment were based on comparable n values used for similar experiments in the literature. All n's were based on biological replicates. Data are presented as mean ±standard error of the mean (SEM) unless otherwise stated.
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###### Macro to estimate number of capillaries in 2 P imaging stacks.

Code can be executed in either Fiji or ImageJ. It is run on imaging groups of stacks of vasculature in the horizontal plane (x,y,z, stacks). Output is file with % of vascular pixels for each sub stack as well as number of vascular length pixels.

10.7554/eLife.33670.022

###### Modelling of capillary loss over time based on experimental data.

Code is run in Matlab. Program opens an excel sheet (Data [@bib42]) with branch order distribution and assigned risk of obstruction (see methods, [Figure 4](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Output is capillary numbers (by branch order), absolute and relative risk of obstruction and fractional distribution of branch orders, over time.

10.7554/eLife.33670.023

###### Mod_data excel file, loads into Source Code two to model obstruction risk across branch orders based on the experimentally determined distribution of spontaneous obstructed capillaries.

10.7554/eLife.33670.024

###### PDF instructions relating to Source code 2.

10.7554/eLife.33670.025
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Decision letter

Kleinfeld

David

Reviewing Editor

University of California, San Diego

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Mapping the fates of obstructed cerebral capillaries reveals a mechanism for age related capillary loss\" for consideration by *eLife*. Your article has been reviewed by three very strong peer reviewers, and the evaluation has been overseen by David Kleinfeld as the Reviewing Editor and David Van Essen as the Senior Editor. The following outside reviewers involved in review of your submission have agreed to reveal their identity: Jaime Grutzendler (Reviewer \#1); David A Boas (Reviewer \#3). The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary: Craig Brown and colleagues show that blocking flow in cortical microvessels can lead to substantial pruning of these vessels, exacerbating the initial damage and potentially increasing the risks of hypoxia after the accumulation of occlusions with aging.

Decision: All reviewers, and we as editors, congratulate you on completing an important and thorough study. However, there are many queries raised by the reviewers that require changes to the text before final decision can be made. No additional experiments are needed.

One reoccurring query is on the use of 4 μm microspheres for the block as opposed to large spheres or natural plaques. To paraphrase reviewer 2: \"It is essential that the authors clarify that their rates of recanalization, pruning and angiophagy are based on the use of 4um beads and that these analyses would be different based on beads of larger sizes/different composition. Critically, the quantification would almost certainly be different if they were using more natural embolic materials (blood clots or cholesterol emboli), which could markedly increase the retention within capillaries and therefore increase the relative frequency of other recanalization mechanisms different from hemodynamic washout.\"

There are also qualms about priority. To paraphrase reviewer 2: \"The assertion that the authors show angiophagy in capillaries for the first time is incorrect as it has already been shown in Lam et al., (Figure 1D) that capillaries are capable of angiophagy.\" Likewise, the comment that \"With small vessel (capillary) obstructions, angiophagy based recanalization is likely avoided since the capillary can extrude the obstruction back into the circulation which is not possible with large obstructions\" is incorrect. As shown in Grutzendler at al., 2014 Figure 1A, large obstructions can also be washout out within hours.\"

Finally, while the reviewers disagree about the likely contribution of pericytes to the loss of capillaries, we note that pericytes are important in vascular maintenance and integrity and the possible role of pericytes in regards to the failure to recanulate and the onset of subsequent pruning should be discussed.

*Reviewer \#1:*

In this manuscript, Reeson et al. use 2-photon in vivo imaging to characterize the incidence and consequences of cortical capillary obstructions. The authors perform time-lapse to follow capillaries blocked spontaneously (\>20 min) or with 4µm microspheres injected through the tail vein to track the fate of these vessels. They also model capillary loss with aging and examine the role of VEGF-R2 signaling on rates of recanalization. Overall, the project is well executed and the tracking of capillary fates over time is a solid contribution to the field. There are clear aspects of this study that are interesting, specifically those related to the finding of relatively high rates of microvascular pruning even in vessels that had previously been occluded and underwent recanalization. Also, the results with VEGFR manipulation showing an effect on the pruning outcome are interesting.

Despite this, the authors make conclusions that are not supported by the data. They fail to explain all the caveats associated with using 4µm microbeads and make claims of novelty when previous papers already exist showing similar findings. I strongly suggest that the authors reword the manuscript to better reflect the most interesting and novel aspects i.e. vascular pruning after transient occlusion and the potential role for VEGF rather than the currently vague title. It is also important to reduce emphasis given in the text to the quantification and outcomes of capillary recanalization, as the model used in these experiments is associated with incredibly high washout rates and cannot be used as a gold standard model for capillary obstructions.

1\) The authors interpret their 4um microsphere model of capillary obstructions as a robust model to measure capillary recanalization frequency. Use of a 4um microsphere as the sole method to model capillary obstruction is problematic, as the bead is so small that hemodynamic force will almost certainly cause the majority of microspheres to be washed out and does not reflect what happens with more natural embolic composition and slightly larger sizes. Use of slightly larger microspheres (5/6µm) would still result in capillary obstruction, however their rates of washout and transvascular embolic extravasation (\"Angiophagy\") would likely be completely different from the quantification presented here. It is essential that the authors clarify throughout the manuscript that their rates of recanalization, pruning and angiophagy are based on the use of 4um beads and that these analyses would be different based on beads of larger sizes/different composition. Critically, the quantification would almost certainly be different if they were using more natural embolic materials (blood clots or cholesterol emboli) that are not plastic and smooth as the microspheres, which would markedly increase the retention within capillaries and therefore increase the relative frequency of other recanalization mechanisms different from hemodynamic washout. Thus, as it is, I don\'t think the relative contributions of each recanalization mechanism can be generalized from the existing data. Authors should add a section discussing the caveats and limitations of the study i.e. the problems associated with using 4um, plastic microspheres that are highly susceptible to washout. Statements such as \"Tracking natural or microsphere induced obstructions revealed that most capillaries recanalize by pushing obstructions back into the circulation rather than through the capillary wall\" should be removed, as the authors cannot make these conclusions based on the use of 4um plastic spherical beads.

3\) The assertion that the authors show angiophagy in capillaries for the first time is incorrect as it has already been shown in Lam et al., 2010 (Figure 1D) that capillaries are capable of angiophagy. This wording should be corrected. Likewise, the comment that \"With small vessel (capillary) obstructions, angiophagy based recanalization is likely avoided since the capillary can extrude the obstruction back into the circulation which is not possible with large obstructions\" is incorrect. As shown in Grutzendler at al., 2014 Figure 1A, large obstructions can also be washout out within hours. These inaccuracies should be corrected throughout the manuscript.

4\) The title of the paper does not reflect the actual novel findings about vascular pruning and VEGF signaling but places too much emphasis on aging and mapping of recanalized capillaries. Title should be reworded to highlight the novel results.

5\) Measurements of capillary occlusion and relative rates of microvascular spontaneous stasis have previously been measured by in vivo dynamic imaging (Erdener at al., 2017). This paper should be acknowledged and referenced in the manuscript.

6\) The concept of vascular pruning as a result of obstruction/recanalization is interesting and merits further examination. However, the images in Figure 2F have been cropped asymmetrically and it is difficult to see whether or not these are the same vessels over 21 days. Better quality and more examples of pruning images are needed, even just for supplementary data.

7\) In Figure 5, the concept of very high and very low VEGF-R2 co-localization with endothelium in recanalized vessels is confusing. Is this due to the duration of how long the obstruction had been there? What causes these differences in expression in recanalized vessels?

8\) In Figure 5 did the authors confirm microsphere density/load was similar across groups (saline vs. VEGF-A; vehicle vs. Tamoxifen; vehicle vs. SU5416) acutely e.g. 30 min post microsphere injection? Microsphere load could be heterogeneous (despite injecting the same number of microspheres) and differences in number may have existed at earlier stages which therefore explains the differences in microsphere load seen at 24h, 4d and 21d respectively.

9\) More details about density normalization (Figure 5) is needed in the Materials and methods. Exact numbers should be included in the legend or Results section regarding raw numbers of microsphere density. Raw numbers should also be included in Results section (subsection "Superficial and lower order cortical capillaries are prone to obstruction") regarding number of spontaneous obstructions seen at start of imaging period (persisting \>20min) in 10 out of 16 mice.

10\) In mice treated with VEGF-A, was there an increase in pruning over time i.e. what were capillary fates in VEGF-A treated mice? Furthermore, was there an increase in disruption in RBC velocity and flux?

*Reviewer \#2:*

The study by Reeson and colleagues tracks spontaneous and microsphere-induced obstructions of cortical capillaries that occur preferentially in superficial layers and lower order vessel branches, with a higher prevalence in aged mice. They observed that about 30% of obstructed capillaries undergo pruning, with no evidence of compensatory angiogenesis. Endothelial VEGFR2 was identified as a crucial factor mediating capillary recanalization and pruning. The manuscript\'s topic is novel and timely, as increasing literature is recognizing the importance of capillary regulation of CBF flow that contributes to neuronal brain health and has relevance to pathophysiology of various neurological disorders. This study would benefit by addressing the following comments:

1\) Have the authors considered the contribution of pericytes to their observed capillary constriction and pruning, given the observations that pericytes contribute to \"no reflow\" phenomena in ischemic conditions (Nature. 2014 Apr 3;508(7494):55-60, Nat Med. 2009 Sep;15(9):1031-7)? At minimum, the possible role of pericytes in regards to the failure to recanulate, delayed vessel constriction, and pruning should be discussed.

2\) Is there any blood-brain barrier leakage from the vessels with occlusions? For example, extravascular fibrin/fibrinogen deposits around transient or permanent occlusion sites?

3\) There is an implicit assumption that vessels with fluid in them will be labeled with the dyes injected into the vasculature, regardless of whether there is RBC flow. This caveat should be noted, particularly since much of the data relies on this assumption.

4\) In Figure 2F, the vessels connected to the pruned vessel appear to deform significantly, particularly at the 15 day time point. How frequently did this phenomenon occur, and were the distances between the two vessels on either side of the pruned vessel permanently altered? It would be interesting to know if the surrounding vessels were remodeled/repositioned in response to the pruning.

5\) For the VEGF-A injection experiments, were vascular diameters altered compared to vehicle injections?

6\) In the discussion of VEGF-R2 the authors note that VEGF-R2 can upregulate eNOS in endothelial cells. However, it was recently reported that NO is not a major capillary dilator in mouse cortex (Nat Neurosci. 2016 Dec;19(12):1619-1627).

7\) Red blood cell (RBC) streaking/velocity measurements:

A\) The authors image RBCs \"streaking\" through the image (first Results paragraph). How long was each vessel imaged in order to determine RBC flow?

B\) The details of RBC measurements are not well described or referenced (if the author\'s technique was based on published work) in the Materials and methods section. This brings up many questions: How were the line scans acquired and at what scan rate? How long was blood flow imaged in order to determine RBC velocity in the vessel segments? If the velocity was measured \"by hand\" as the methods seem to describe, the method should be described in more detail, as most labs use freely available automated software (i.e. PLoS One. 2012;7(6):e38590 and J Comput Neurosci. 2010 Aug;29(1-2):5-11). The methods indicate only 3 or 9 (it is unclear; subsection "Analysis of vascular structure and flow") RBC streaks were used for analysis per vessel. With so few measurements per vessel, how did the authors account for natural variation like heart beat when determining velocity (see e.g. PLoS One. 2012;7(6):e38590)?

8\) The purpose of the Figure 5B inset is unclear. The same data is shown in the main panel in a more useful organization. Also, the caption should be explained better to describe the \"\<20%\" and \"\>20%\" notations for recanalized vessels.

9\) Is there any difficulty with microspheres aggregating during in vivo experiments?

10\) The present manuscript only examines vascular responses in the somatosensory cortex and references the expected number of capillary obstructions in the cortex. There may be regional differences in the brain and certain regions (areas of cortex or other regions) may be more or less susceptible to capillary obstructions and/or pruning. Regional vulnerability has relevance to pathophysiology -- this is an important concept that should be added to the Discussion.

11\) Please explain or correct the use of a 1 way ANOVA with t-test.

12\) Please provide more description for Figure 2H in the caption.

13\) The difference in vascular density is not very apparent in Figure 4A.

14\) Since much of the data is parsed by vessel, not animal, please indicate how many vessels were imaged per animal (typical or range).

15\) In many images, it is hard to see the green of the vessel lumen against the magenta of the vascular dye. Perhaps the contrast can be adjusted to better balance the two signals.

16\) For immunohistochemistry analysis, how were 50 μm sections projected from 40 μm thick slices (subsection "Phosphorylated VEGF-R2 immunohistochemistry and analysis")?

*Reviewer \#3:*

This study focuses on in vivo measurements in awake and anesthetized mice to detect and quantify the long-lasting (\>20 min) capillary obstructions utilizing two-photon microscopy time lapse imaging. They expand their findings with endothelial labeling in stalled capillaries with help of lipophilic microspheres and they also induce a higher number of obstructions by injecting 4-µm fluorescent microspheres. They show that although majority of these obstructions are resolved over time, around 30% of them lead to pruning of capillaries, which can predict age-related decrease in capillary density. Downregulation VEGF signaling in endothelial cells, on the other hand, promote resolution of capillary obstructions, albeit with yet unidentified mechanisms, as the authors appreciate.

This is a very comprehensive study with an excellent design, proper ways of analysis and a very good discussion on findings. The focus of the study is a very interesting and previously underrecognized phenomenon, which can lead to highly innovative future work in cerebral physiology and various pathological models. I nevertheless had some scientific concerns and these points should be addressed for proper conclusion on the findings.

1\) It is claimed that injection of 4µm microspheres causes capillary obstructions by themselves. However it is possible that the obstructions are actually caused by blood cells and the microspheres are simply stuck in those capillaries because of lack of flow. The authors did a great deal of work to show that microsphere injection does not lead to microglial activation, physiological variables or blood chemistry profile. However I feel that the most important data to check is the blood cell counts before and after injection of microspheres. An increase in leukocyte count may be happening after microsphere injection, which can readily increase the fraction of capillary stalls. Moreover, another possibility is that these microspheres are phagocytosed by leukocytes and they are actually tracking leukocytes plugging the capillaries and rather than the suggested mechanism of angiophagy, leukocytes may be migrating through the endothelia with fluorescent particles inside. This is a major distinction to be made about the actual pathophysiology.

2\) The authors conclude that the obstructions are mainly in lower branch-order capillaries and rather superficially located. In the methods, they describe that they imaged down to 350 µm below cortical surface in vivo. However in Figure 1B they present data on fraction of obstructed vessels down to 1300 µm. Is it possible to get high quality in vivo imaging that deep with FITC and rhodamine fluorophores? Can the relatively lower fraction of stalled capillaries at deeper regions simply be a detection problem because of lower quality? This should be discussed and also the absolute number of capillaries across different depths should be presented in the same panel. Also, while the authors state in the Discussion that this preference of blockages occurring in the lower order branches is consistent with the Erdner and Boas paper, it actually seems to be inconsistent with Figure 5 of that paper which shows that more obstructions occur in the higher order branches near the veins. What gives rise to this discrepancy? Longer lasting blockages as studied here versus more transient blockages studied in Erdener and Boas?

3\) It is concluded that anesthesia did not have any effect on the numbers of capillary obstructions. However, it is mentioned that awake mice were also briefly anesthetized before the imaging session before they were fixed to the imaging setup. Could this initial brief anesthesia have long-lasting effects on obstructions even if the mice are awake during the actual imaging? The recently publication by Erdener and Boas, that they cite, does indicate an effect of anesthesia.

10.7554/eLife.33670.029

Author response

> Decision: All reviewers, and we as editors, congratulate you on completing an important and thorough study. However, there are many queries raised by the reviewers that require changes to the text before final decision can be made. No additional experiments are needed.
>
> One reoccurring query is on the use of 4 μm microspheres for the block as opposed to large spheres or natural plaques. To paraphrase reviewer 2: \"It is essential that the authors clarify that their rates of recanalization, pruning and angiophagy are based on the use of 4um beads and that these analyses would be different based on beads of larger sizes/different composition. Critically, the quantification would almost certainly be different if they were using more natural embolic materials (blood clots or cholesterol emboli), which could markedly increase the retention within capillaries and therefore increase the relative frequency of other recanalization mechanisms different from hemodynamic washout.\"

We agree that we must be very clear in our manuscript that the rate of recanalization, pruning and angiophagy can be affected by the specific type of embolus used. Although we found similar rates of recanalization and pruning for obstructions induced with microspheres versus those that occurred spontaneously (see Figure 2D and Results subsection "Fates of obstructed cortical capillaries", last paragraph: 30.2% vessels were pruned when obstructed with microsphere versus 36.7% with spontaneous occlusion, p = 0.48), we acknowledge and discuss work from Grutzendler showing that rates of washout/angiophagy differ between plastic microspheres and natural embolic materials. We have altered the text to reflect this in the Abstract removing the phrase "capillaries recanalized by pushing obstructions back into circulation rather than through the capillary wall". As well in the Results we state: "However, we should note that we were unable to measure rates of angiophagy associated with spontaneous, naturally occurring emboli, which likely would have influenced the route of recanalization (washout vs. angiophagy)." Lastly in the Discussion under "microsphere model of obstruction", we now state: "However, there are important caveats that should be noted with the microsphere model. \[...\] For example, Lam et al. showed different rates of washout versus angiophagy between natural emboli compared to microspheres (Lam et al., 2010)."

> There are also qualms about priority. To paraphrase reviewer 2: \"The assertion that the authors show angiophagy in capillaries for the first time is incorrect as it has already been shown in Lam et al., 2010 (Figure 1D) that capillaries are capable of angiophagy.\" Likewise, the comment that \"With small vessel (capillary) obstructions, angiophagy based recanalization is likely avoided since the capillary can extrude the obstruction back into the circulation which is not possible with large obstructions\" is incorrect. As shown in Grutzendler at al., 2014 Figure 1A, large obstructions can also be washout out within hours.\"

We agree and appreciate the correction. We have changed the text in the Discussion, stating "Our finding of an angiophagy-like process where endothelial cells engulf and extrude emboli through the vessel wall replicates previous findings of Lam et al. (Lam et al., 2010; Grutzendler et al., 2014). \[...\] For example, larger occlusions (\> 4 µm) would have more severe consequences such as hypoxia and cell death (Tennant and Brown, 2013) which can trigger major structural changes in the vascular endothelium through hypoxia inducible factors." and we have removed the statement "With small vessel (capillary) obstructions, angiophagy based recanalization is likely avoided since the capillary can extrude the obstruction back into the circulation (see Figure 2---video 1), which is not possible with large obstructions."

> Finally, while the reviewers disagree about the likely contribution of pericytes to the loss of capillaries, we note that pericytes are important in vascular maintenance and integrity and the possible role of pericytes in regards to the failure to recanulate and the onset of subsequent pruning should be discussed.

This is an excellent point, and one that we had considered ourselves. However, in order to do this important topic justice, a full length study would be required which we think would be best left for future investigation. We now discuss this topic in the "Mechanisms of recanalization" section of the Discussion, adding "Another possibility that will require further study is whether pericytes facilitate recanalization or pruning. \[...\] Pericytes could also play a significant role in vessel pruning since they are hotspots of matrix metalloprotease activity associated with BBB disruption (Underly et al., 2016), which is needed for remodeling of the extracellular matrix and basement membrane around capillaries."

> Reviewer \#1:
>
> In this manuscript, Reeson et al. use 2-photon in vivo imaging to characterize the incidence and consequences of cortical capillary obstructions. The authors perform time-lapse to follow capillaries blocked spontaneously (\>20 min) or with 4µm microspheres injected through the tail vein to track the fate of these vessels. They also model capillary loss with aging and examine the role of VEGF-R2 signaling on rates of recanalization. Overall, the project is well executed and the tracking of capillary fates over time is a solid contribution to the field. There are clear aspects of this study that are interesting, specifically those related to the finding of relatively high rates of microvascular pruning even in vessels that had previously been occluded and underwent recanalization. Also, the results with VEGFR manipulation showing an effect on the pruning outcome are interesting.
>
> Despite this, the authors make conclusions that are not supported by the data. They fail to explain all the caveats associated with using 4µm microbeads and make claims of novelty when previous papers already exist showing similar findings. I strongly suggest that the authors reword the manuscript to better reflect the most interesting and novel aspects i.e. vascular pruning after transient occlusion and the potential role for VEGF rather than the currently vague title. It is also important to reduce emphasis given in the text to the quantification and outcomes of capillary recanalization, as the model used in these experiments is associated with incredibly high washout rates and cannot be used as a gold standard model for capillary obstructions.
>
> 1\) The authors interpret their 4um microsphere model of capillary obstructions as a robust model to measure capillary recanalization frequency. Use of a 4um microsphere as the sole method to model capillary obstruction is problematic, as the bead is so small that hemodynamic force will almost certainly cause the majority of microspheres to be washed out and does not reflect what happens with more natural embolic composition and slightly larger sizes. Use of slightly larger microspheres (5/6µm) would still result in capillary obstruction, however their rates of washout and transvascular embolic extravasation (\"Angiophagy\") would likely be completely different from the quantification presented here. It is essential that the authors clarify throughout the manuscript that their rates of recanalization, pruning and angiophagy are based on the use of 4um beads and that these analyses would be different based on beads of larger sizes/different composition. Critically, the quantification would almost certainly be different if they were using more natural embolic materials (blood clots or cholesterol emboli) that are not plastic and smooth as the microspheres, which would markedly increase the retention within capillaries and therefore increase the relative frequency of other recanalization mechanisms different from hemodynamic washout. Thus, as it is, I don\'t think the relative contributions of each recanalization mechanism can be generalized from the existing data. Authors should add a section discussing the caveats and limitations of the study i.e. the problems associated with using 4um, plastic microspheres that are highly susceptible to washout. Statements such as \"Tracking natural or microsphere induced obstructions revealed that most capillaries recanalize by pushing obstructions back into the circulation rather than through the capillary wall\" should be removed, as the authors cannot make these conclusions based on the use of 4um plastic spherical beads.

Please see our first response to the decision comments above..

> 3\) The assertion that the authors show angiophagy in capillaries for the first time is incorrect as it has already been shown in Lam et al., 2010 (Figure 1D) that capillaries are capable of angiophagy. This wording should be corrected. Likewise, the comment that \"With small vessel (capillary) obstructions, angiophagy based recanalization is likely avoided since the capillary can extrude the obstruction back into the circulation which is not possible with large obstructions\" is incorrect. As shown in Grutzendler at al., 2014 Figure 1A, large obstructions can also be washout out within hours. These inaccuracies should be corrected throughout the manuscript.

Please see our second response to the decision comments above.

> 4\) The title of the paper does not reflect the actual novel findings about vascular pruning and VEGF signaling but places too much emphasis on aging and mapping of recanalized capillaries. Title should be reworded to highlight the novel results.

We agree, finding a title that is both succinct and encompassing of the most novel aspects is always challenging. We have changed the title to better reflect an emphasis on VEGF signaling.

"VEGF signaling regulates the fate of obstructed capillaries in mouse cortex"

*5) Measurements of capillary occlusion and relative rates of microvascular spontaneous stasis have previously been measured by* in vivo *dynamic imaging (Erdener at al., 2017). This paper should be acknowledged and referenced in the manuscript.*

We are aware of the excellent work by Erdener at al. and cited it in our original submission. We have also added another reference to this paper in the Introduction: "A recent study used Optical Coherence Tomography to estimate that over 9 minutes, up to 7.5% of capillaries experienced a stall (Erdener et al., 2017)."

> 6\) The concept of vascular pruning as a result of obstruction/recanalization is interesting and merits further examination. However, the images in Figure 2F have been cropped asymmetrically and it is difficult to see whether or not these are the same vessels over 21 days. Better quality and more examples of pruning images are needed, even just for supplementary data.

We can see how it may appear to the reviewer that the images in Figure 2F were cropped asymmetrically, however that is due to the occasional distortion of adjacent vessels during pruning (see response to Reviewer 2 comment 4). To provide additional clarity we have added several new examples of obstruction/recanalization in Figure 2---figure supplement 1A, Figure 2---figure supplement 2B.

> 7\) In Figure 5, the concept of very high and very low VEGF-R2 co-localization with endothelium in recanalized vessels is confusing. Is this due to the duration of how long the obstruction had been there? What causes these differences in expression in recanalized vessels?

The wide disparity of activated VEGF-R2 (p-VEGF-R2) colocalization with recanalized vessels 3 hours post-microsphere injection surprised us as well. Specifically, we noted that rather than a gaussian range of values, we instead found two very distinct, non-overlapping, populations with very high or low VEGF-R2 colocalization (Figure 5B insert). While our DiI labelling technique allowed us to spatially "stamp" recanalized vessels, it had limitations in the time domain. Assuming a minimum time required for DiI to label a vessel (\<30 minutes), we could not know precisely how long the obstructed vessel had regained flow (likely anywhere from just minutes to 2.5 hours). Based on previous studies showing that VEGF-R2 signaling is sensitive to shear stress (increased flow leads to increased phosphorylated VEGF-R2) and our VEGF-R2 inhibitor/ gene knockdown experiments showing that reducing VEGF-R2 enhances recanalization, we suspect that low pVEGF-R2 colocalization would correlate with vessels that had recently regained blood flow (with respect to the time of killing the mouse). This would also explain why most obstructed vessels have a natural tendency to recanalize, as well as why pVEGF-R2 colocalization was significantly lower in vessels 30 minutes after microsphere injection. With respect to recanalized vessels with high pVEGF-R2 colocalization 3 hours after injection, we speculate these are vessels that had regained flow for an extended period of time, thereby allowing shear stress induced VEGF-R2 phosphorylation to increase substantially.

> 8\) In Figure 5 did the authors confirm microsphere density/load was similar across groups (saline vs. VEGF-A; vehicle vs. Tamoxifen; vehicle vs. SU5416) acutely e.g. 30 min post microsphere injection? Microsphere load could be heterogeneous (despite injecting the same number of microspheres) and differences in number may have existed at earlier stages which therefore explains the differences in microsphere load seen at 24h, 4d and 21d respectively.

This is an important point, and we thank the reviewer for bringing it up. It is an assumption in our histological experiments (where microsphere density is quantified) that even with perfectly identical injections of microspheres with control and experimental groups run in parallel, the starting obstruction load in the brain could differ between experimental groups. With VEGF-R2 inhibitor experiments, mice were randomly assigned to SU5416 or vehicle groups 30 mins after microsphere injection, thus there was no initial bias in assigning treatment groups. However to confirm this, we examined our in vivodata at the first imaging point (+30 min post-injection) and found no difference in initial microsphere density (652 ± 224 microspheres / mm^3^ for vehicle injected mice versus 562 ± 200 microspheres / mm^3^ for SU5416 treated mice, t~(6)~ = 0.25, p = 0.8).

For genetic knockdown of VEGF-R2, Tamoxifen was given prior to injection of microspheres, possibly influencing the number of microspheres reaching the brain. However, our in vivo imaging data 30 min post microsphere injection did not show a significant difference in the number of initial obstructions (509 ± 234 microspheres / mm^3^ for vehicle injected mice versus 328 ± 70 microspheres / mm^3^ for Tamoxifen treated, t~(10)~ = 2.0, p =0.07). We now include these analyses in the last paragraph of the results. More importantly, by following the same obstructed vessels over time in vivo(for both VEGF-R2 inhibition and knockdown experiments),initial microsphere load was not a factor in explaining the outcome of an obstructed vessel. In all experiments, we observed the same strong effects in each experimental group (regardless of variability in initial load) for both histological and in vivo time lapse imaging studies. In summary, we are confident that variability in initial microsphere density could not explain our converging lines of evidence indicating a key role for VEGF-R2 in capillary recanalization.

> 9\) More details about density normalization (Figure 5) is needed in the Materials and methods. Exact numbers should be included in the legend or Results section regarding raw numbers of microsphere density. Raw numbers should also be included in Results section (subsection "Superficial and lower order cortical capillaries are prone to obstruction") regarding number of spontaneous obstructions seen at start of imaging period (persisting \>20min) in 10 out of 16 mice.

We have amended the Materials and methods sections to better clarify the normalization procedure, "To limit variability in total numbers of microspheres injected, mice were run in balanced groups of control and experimental conditions and received injections from the same diluted stock of microspheres. \[...\] Normalized ratios were then averaged across cohorts (typically each experiment consisted of 2-4 cohorts)." and have added raw microsphere density to the Figure 5 legend. With respect to spontaneous obstructions, we have added the raw number to both the legend and in the Results section, "(persisted \> 20 min, 20 obstructed capillaries in 10 animals, range of 1-4 per mouse)".

> 10\) In mice treated with VEGF-A, was there an increase in pruning over time i.e. what were capillary fates in VEGF-A treated mice? Furthermore, was there an increase in disruption in RBC velocity and flux?

This is an intriguing question, as our data shows that 24 hours after microsphere injections, VEGF-A treated mice had a significantly higher number of microspheres in the cortex. However, we do not have a concrete answer to this question since we did not undertake these challenging experiments of following individual obstructions over a 21 day period. This is largely due to the challenging task of chronic i.c.v. infusion of VEGF (with cannula hardware cemented to the skull) in mice with hardware needed for long-term imaging through a cranial window (metallic ring, dental cement etc.). However, with that said, we do know that there is a high probability for long-lasting obstructions (in this case lasting at least 24 hours) to lead to vessel pruning.

> Reviewer \#2:
>
> The study by Reeson and colleagues tracks spontaneous and microsphere-induced obstructions of cortical capillaries that occur preferentially in superficial layers and lower order vessel branches, with a higher prevalence in aged mice. They observed that about 30% of obstructed capillaries undergo pruning, with no evidence of compensatory angiogenesis. Endothelial VEGFR2 was identified as a crucial factor mediating capillary recanalization and pruning. The manuscript\'s topic is novel and timely, as increasing literature is recognizing the importance of capillary regulation of CBF flow that contributes to neuronal brain health and has relevance to pathophysiology of various neurological disorders. This study would benefit by addressing the following comments:
>
> 1\) Have the authors considered the contribution of pericytes to their observed capillary constriction and pruning, given the observations that pericytes contribute to \"no reflow\" phenomena in ischemic conditions (Nature. 2014 Apr 3;508(7494):55-60, Nat Med. 2009 Sep;15(9):1031-7)? At minimum, the possible role of pericytes in regards to the failure to recanulate, delayed vessel constriction, and pruning should be discussed.

This is an excellent point, and one that we had considered ourselves. However, in order to do this important topic justice, a full length study would be required which we think would be best left for future investigation. We now discuss this topic in the "Mechanisms of recanalization" section of the Discussion, adding "Another possibility that will require further study is whether pericytes facilitate recanalization or pruning. \[...\] Pericytes could also play a significant role in vessel pruning since they are hotspots of matrix metalloprotease activity which is needed for remodeling of the extracellular matrix and basement membrane around capillaries (Forde et al., 2002)."

> 2\) Is there any blood-brain barrier leakage from the vessels with occlusions? For example, extravascular fibrin/fibrinogen deposits around transient or permanent occlusion sites?

We occasionally noticed labelled plasma leak from obstructed capillaries at or near the site of an obstruction, appearing as a small extravascular plume 30 min -- 1.5 hour after the initial obstruction. However, these were relatively rare occurrences for both microsphere (5 vessels out of 162 total) and spontaneously obstructed capillaries (2 vessels out of 21 total). For VEGFR-2 inhibition, only 1 out of 93 vessels showed BBB disruption and none were detected in VEGF-R2 knockdown experiments. We did not find any relationship between BBB disruption and whether an obstruction was cleared or pruned.

> 3\) There is an implicit assumption that vessels with fluid in them will be labeled with the dyes injected into the vasculature, regardless of whether there is RBC flow. This caveat should be noted, particularly since much of the data relies on this assumption.

This is an important caveat that should be explicitly stated in the text. We also noted that while using our *Tek*-GFP labelled endothelial mice, we never saw completely empty lumens (i.e. *Tek*-GFP labelled vessels with no dye infused plasma). Even in the cases of obstruction and pruning (with no RBC flow) some labelled plasma always diffused into parts of the obstructed vessel. We have added a sentence in the Microsphere model section of the Discussion: "Our measurements were based on intravenous injection of fluorescent dyes, therefore labelling flowing capillaries in the brain with very high signal to noise. However, this could slightly overestimate the density of patent capillaries since injected plasma dyes also filled stalled capillaries given that we never found a *Tek*-GFP labelled capillary without fluorescent dye present in it."

> 4\) In Figure 2F, the vessels connected to the pruned vessel appear to deform significantly, particularly at the 15 day time point. How frequently did this phenomenon occur, and were the distances between the two vessels on either side of the pruned vessel permanently altered? It would be interesting to know if the surrounding vessels were remodeled/repositioned in response to the pruning.

This is an interesting observation. We agree that in the act of pruning, adjacent vessels could appear somewhat deformed, such as pulling together. Therefore, we measured the shortest straight distance (in 3D) between starting branch points and final distances (before and after the adjoining capillary was pruned). The distance between 33 pairs of vessels in 10 mice was measured where the same points (after pruning) could be unambiguously determined by landmarks and endothelial cell bodies (range 1-7 pairs of vessels per mouse). We found \~36% (12/33) were slightly further apart after pruning (average change in distance from time 0 to +21 days: +5.77 ± 8.5 μm, range 0.4-29 μm). Conversely \~64% of vessels were closer together after pruning (21/33, average change in distance from time 0 to +21 days: -8.67 ± 7.7 μm, range 1.3-32 μm). Statistically speaking, there was no significant difference in the average distance between vessel segments before or 21 days after pruning. This data is now included in the Results section and Figure 2---figure supplement 1: "During pruning we occasionally found that the adjacent capillary segments appeared closer together or further apart. However, by measuring inter-capillary distance at time 0 and +21 days, on average we found no significant lasting deformation of the newly separated capillaries compared to controls (Figure 2---figure supplement 1)."

> 5\) For the VEGF-A injection experiments, were vascular diameters altered compared to vehicle injections?

Unfortunately, we were unable to answer this question with our VEGF injection experiments. We were primarily interested in the effects of VEGF on microsphere clearance and used a histology approach. If we were to assess this question 24 hours after VEGF injection in post mortem fixed tissue, any VEGF induced changes to vessel diameter would likely have dissipated and/or be obscured by the loss of blood pressure and shrinkage related to post-mortem tissue processing. While this is a question we are still interested in answering, particularly as there is evidence that VEGF can alter blood flow (Hein, T. W., et al. (2015). Investigative Ophthalmology and Visual Science 56(9): 5381-5389), properly answering this question would require technically challenging experiments combining in vivo imaging with i.c.v. cannula infusion of VEGF. However, we did note in the manuscript that SU5416 based inhibition of VEGF-R2 signaling did not have a detectable effect on capillary width in our in vivo imaging experiments. Specifically, there was no significant difference in average capillary width when measured before and 90 mins after SU5416 injection (paired t-test t~(29)~=0.9, p= 0.37). We have added this data to Figure 5---figure supplement 2G.

> 6\) In the discussion of VEGF-R2 the authors note that VEGF-R2 can upregulate eNOS in endothelial cells. However, it was recently reported that NO is not a major capillary dilator in mouse cortex (Nat Neurosci. 2016 Dec;19(12):1619-1627).

We have added this caveat to the text in the Mechanisms of Recanalization section of the Discussion "However a recent study has questioned the role of NO as a major capillary dilator (Mishra et al., 2016), thus other pathways may be involved"

> 7\) Red blood cell (RBC) streaking/velocity measurements:
>
> A\) The authors image RBCs \"streaking\" through the image (first Results paragraph). How long was each vessel imaged in order to determine RBC flow?

Each vessel was imaged for at least \~6.5 seconds (3.2475 seconds/frame, 2um steps) during initial x,y,z imaging. Any vessel that had no observable streaking within this imaging volume was then followed up by linescans (\~3 sets of line scans 30 seconds apart) to confirm the lack of RBC flow. Then each region was again imaged 20 min later in x,y,z stack (again \~6.5 seconds minimum for a \~4 μm vessel perfectly in xy plane) and then again followed up by linescans to be consider obstructed for greater than 20 min.

> B\) The details of RBC measurements are not well described or referenced (if the author\'s technique was based on published work) in the Materials and methods section. This brings up many questions: How were the line scans acquired and at what scan rate? How long was blood flow imaged in order to determine RBC velocity in the vessel segments? If the velocity was measured \"by hand\" as the methods seem to describe, the method should be described in more detail, as most labs use freely available automated software (i.e. PLoS One. 2012;7(6):e38590 and J Comput Neurosci. 2010 Aug;29(1-2):5-11). The methods indicate only 3 or 9 (it is unclear; subsection "Analysis of vascular structure and flow") RBC streaks were used for analysis per vessel. With so few measurements per vessel, how did the authors account for natural variation like heart beat when determining velocity (see e.g. PLoS One. 2012;7(6):e38590)?

We have clarified our linescan analysis in the Materials and methods stating: "To measure RBC velocity, two blinded researchers chose 3 equally spaced apart RBC streaks from each line scan (each linescan was on average 30.83 ± 1 ms per scan, 2 μm/pixel) and using built in functions of Olympus Fluoview software measured the inverse slope (Δ time/ Δ distance). \[...\] Therefore, each single vessel RBC velocity at each timepoint was the average of 18 independent blinded measurements (2 experimenters' x 3 linescans x 3 RBC slopes)."

To further verify that our measurements were comparable to those achieved by automated programs, we randomly selected 20 linescans to measure using the available MATLAB program from PLoS One. 2012;7(6):e38590. From this set we compared average manual versus automated RBC velocity and found no difference (see [Author response image 1](#respfig1){ref-type="fig"}). Two linescans were excluded due to poor signal to noise that was incompatible with the automated program and gave physiologically impossible values. While the short duration of each linescan (average 30.83 ± 1 ms) prevents us from excluding the effects of cardiac activity, we did not find any treatment related changes in heart rate (Figure 5---figure supplement 1-2). Thus, any effects of heartbeat would be equally dispersed across experimental groups.
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> 8\) The purpose of the Figure 5B inset is unclear. The same data is shown in the main panel in a more useful organization. Also, the caption should be explained better to describe the \"\<20%\" and \"\>20%\" notations for recanalized vessels.

We apologize for the lack of clarity regarding Figure 5. As mentioned in our response to reviewer 1 (comment 7), the purpose of the insert in 5B was to show that recanalized capillaries appeared to form to distinct populations, those with very high or low pVEGF-R2 colocalization. These very different distributions were used to justify splitting recanalized vessels into 2 populations (those \< 20% vs those \>20%). We have added clarification to the figure legend "Inset shows the distribution of pVEGF-R2 colocalization values for all recanalized capillaries. Based on this distribution we used a 20% cut off (dotted line) to separate the 2 distinct populations. ".

*9) Is there any difficulty with microspheres aggregating during* in vivo *experiments?*

In rare cases two microspheres would be found obstructing the same vessel, however these vessels were always excluded from analysis. We have added this point in the Materials and methods.

> 10\) The present manuscript only examines vascular responses in the somatosensory cortex and references the expected number of capillary obstructions in the cortex. There may be regional differences in the brain and certain regions (areas of cortex or other regions) may be more or less susceptible to capillary obstructions and/or pruning. Regional vulnerability has relevance to pathophysiology -- this is an important concept that should be added to the Discussion.

This is an excellent point. Although we have shown in Figure 1---figure supplement 4 relatively even distribution in dorsal cortex (from -2mm to +1.5mm relative to bregma), this is admittedly a simplified axis that doesn't take into account possible variability within dorsal cortex or regional differences that may occur in more anterior, posterior and lateral cortical regions. Given this possibility and its relevance to pathology, we have added this point to the Discussion under Microsphere model of obstruction section: "While we did not find any differences in the anterior to posterior distribution of microspheres in dorsal cortex (from -2mm to +1.5mm relative to bregma), this doesn't take into account regional differences that may exist in more anterior, posterior and lateral cortical regions. Since regional vulnerability to capillary obstruction has relevance to pathophysiology, future work will be needed to characterize the risk of obstruction and pruning across the cortical mantle or subcortical regions."

> 11\) Please explain or correct the use of a 1 way ANOVA with t-test.

In all cases we first performed a 1-way ANOVA using Graphpad Prism software, only significant 1-way ANOVAs where followed up by relevant independent 2 tailed t-test. We have clarified this in the Materials and methods section.

> 12\) Please provide more description for Figure 2H in the caption.

We have done this adding to the caption "H) Summary of microsphere obstructed capillary fates 21 days after injection (n=14 mice, 162 obstructions). Numbers in parentheses indicate how many capillaries out of 162 total capillaries underwent pruning, angiophagy or recanalized by extrusion. Average 11 capillaries per mouse, range 6-26."

> 13\) The difference in vascular density is not very apparent in Figure 4A.

The reviewer is correct in noting that difference in vascular density is not stark in Figure 4A. However, since the he overall loss of capillaries was \~ 10%, an obvious difference would be difficult to detect by eye in any representative images.

> 14\) Since much of the data is parsed by vessel, not animal, please indicate how many vessels were imaged per animal (typical or range).

We have added this information (average number of capillaries and range per mouse) to the relevant figure legends.

> 15\) In many images, it is hard to see the green of the vessel lumen against the magenta of the vascular dye. Perhaps the contrast can be adjusted to better balance the two signals.

We have adjusted the contrast in images to better balance the two signals.

> 16\) For immunohistochemistry analysis, how were 50 μm sections projected from 40 μm thick slices (subsection "Phosphorylated VEGF-R2 immunohistochemistry and analysis")?

Thank for pointing out this error, we have changed it to the correct thickness of 50 μm and a projection of 40 μm.

> Reviewer \#3:
>
> This study focuses on in vivo measurements in awake and anesthetized mice to detect and quantify the long-lasting (\>20 min) capillary obstructions utilizing two-photon microscopy time lapse imaging. They expand their findings with endothelial labeling in stalled capillaries with help of lipophilic microspheres and they also induce a higher number of obstructions by injecting 4-µm fluorescent microspheres. They show that although majority of these obstructions are resolved over time, around 30% of them lead to pruning of capillaries, which can predict age-related decrease in capillary density. Downregulation VEGF signaling in endothelial cells, on the other hand, promote resolution of capillary obstructions, albeit with yet unidentified mechanisms, as the authors appreciate.
>
> This is a very comprehensive study with an excellent design, proper ways of analysis and a very good discussion on findings. The focus of the study is a very interesting and previously underrecognized phenomenon, which can lead to highly innovative future work in cerebral physiology and various pathological models. I nevertheless had some scientific concerns and these points should be addressed for proper conclusion on the findings.
>
> 1\) It is claimed that injection of 4µm microspheres causes capillary obstructions by themselves. However it is possible that the obstructions are actually caused by blood cells and the microspheres are simply stuck in those capillaries because of lack of flow. The authors did a great deal of work to show that microsphere injection does not lead to microglial activation, physiological variables or blood chemistry profile. However I feel that the most important data to check is the blood cell counts before and after injection of microspheres. An increase in leukocyte count may be happening after microsphere injection, which can readily increase the fraction of capillary stalls. Moreover, another possibility is that these microspheres are phagocytosed by leukocytes and they are actually tracking leukocytes plugging the capillaries and rather than the suggested mechanism of angiophagy, leukocytes may be migrating through the endothelia with fluorescent particles inside. This is a major distinction to be made about the actual pathophysiology.

Regarding blood cell counts, we did consider this as an important variable. Our blood analysis (shown in Figure 1---figure supplement 2J) measured in microsphere injected mice (at 4 and 21 days post-injection) did not reveal any significant difference in mean hematocrit levels, suggesting a large-scale change in circulating blood cells did not occur. However, we certainly agree that we cannot rule out the possibility that leukocytes engulf and move microspheres across the endothelium and now state this in the Discussion section on Mechanisms of Recanalization: "Our finding of an angiophagy-like process where endothelial cells engulf and extrude emboli through the vessel wall replicates previous findings of Grutzendler lab (Lam et al., 2010; Grutzendler et al., 2014). \[...\] Due to the low incidence (2%) of angiophagy-like events in our microsphere model, we could not extensively characterize this process."

> 2\) The authors conclude that the obstructions are mainly in lower branch-order capillaries and rather superficially located. In the methods, they describe that they imaged down to 350 µm below cortical surface in vivo. However in Figure 1B they present data on fraction of obstructed vessels down to 1300 µm. Is it possible to get high quality in vivo imaging that deep with FITC and rhodamine fluorophores? Can the relatively lower fraction of stalled capillaries at deeper regions simply be a detection problem because of lower quality? This should be discussed and also the absolute number of capillaries across different depths should be presented in the same panel. Also, while the authors state in the Discussion that this preference of blockages occurring in the lower order branches is consistent with the Erdner and Boas paper, it actually seems to be inconsistent with Figure 5 of that paper which shows that more obstructions occur in the higher order branches near the veins. What gives rise to this discrepancy? Longer lasting blockages as studied here versus more transient blockages studied in Erdener and Boas?

We apologize for the lack of clarity in Figure 1. Data in Figure 1B was derived from post mortem histology, thus the full cortex was accessible in coronal slices. We have clarified this in the Figure 1 legend. Furthermore, we have added absolute and relative capillary density values for each depth: "B) Distribution of microsphere obstructed capillaries as it relates to depth from the pial surface determined by confocal imaging from post-mortem brain sections. \[...\] Black line indicates fraction of capillaries by depth (error bars are 95% CI) as well as raw numbers of capillaries / mm^3^ by depth are provided in parentheses." We should note that these relative capillary density fractions closely align with previous estimates from Kleinfeld lab (Tsai et al., 2009 and Blinder et al., 2013).

As to the discrepancy with Erdener and Boas, we meant to suggest that there are similarities in the distribution of obstructions at the arteriole end where the incidence of obstruction peaks at the third order branch with a gaussian distribution around this peak. As for the distribution on the venous side (shown in Erdener and Boas in Figure 5), our data analysis did not address this aspect since we only quantified obstructions as a function of branch order from the arteriole side. We now clarify in the figure legend that we quantified arteriole branch order and mention the discrepancies in the first paragraph of the Discussion: "However, the risk of obstruction was not equally distributed as superficial capillaries of lower branch orders were at highest risk (Figure 1C). While this distribution of obstructed capillaries (as a function of arteriole branch order) bears similarity to a recent study (Erdener et al., 2017), we did not quantify risk relative to venous branch order which may in fact have a higher risk for obstruction (Erdener et al., 2017)."

> 3\) It is concluded that anesthesia did not have any effect on the numbers of capillary obstructions. However, it is mentioned that awake mice were also briefly anesthetized before the imaging session before they were fixed to the imaging setup. Could this initial brief anesthesia have long-lasting effects on obstructions even if the mice are awake during the actual imaging? The recently publication by Erdener and Boas, that they cite, does indicate an effect of anesthesia.

Since our animal ethics protocol requires brief anesthesia to intravenously inject microspheres, we could not systematically determine whether brief exposure to isoflurane to inject beads (\~5-10min) would have altered the number of obstructions relative to those without any anesthesia. Therefore, we acknowledge the possibility that anesthesia could have impacted the number of obstructions and cited Erdener at al. and another recent study (Santisakultarm et al., 2016). This important issue is touched on in the microsphere model of obstruction section in the Discussion: "A second caveat that could not be avoided was that we were unable to inject microspheres without the use of anesthesia. \[...\] Therefore we cannot completely rule out a possible effect of even brief isoflurane exposure (in awake imaging or histology experiments) on microsphere obstruction density, as others have reported anesthetic effects on capillary stalling ((Erdener et al., 2017; Santisakultarm et al., 2016)."
